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The Gram-negative bacillus Burkholderia pseudomallei is the causative agent of 
melioidosis, an infectious disease which is endemic in Southeast Asia and northern 
Australia. B. pseudomallei is well-equipped with many virulent factors which contribute 
to its survival and pathogenicity, one of which is the Type Three Secretion Systems 
(TTSS). Although B. pseudomallei infection can occur through inoculation of 
compromised surface tissues by contaminated soil and water, infection via inhalation 
represents a more natural way of infection in humans. In the context of mucosal infection, 
epithelial cells are the first to be in contact with bacteria and they play an important role 
in initiating and orchestrating the production of mucosal inflammation. Although B. 
pseudomallei interaction with epithelia has been established in non-polarized epithelial 
cells, nothing is known about its interaction with polarized epithelial cells. We showed 
that B. pseudomallei can invade in a transcellular and probably in a paracellular manner 
given that the bacteria could cause reduction in transepithelial electrical resistance 
(TEER) without compromising epithelial cell death. In response to bacterial infection, 
Caco-2 cells can secrete IL-8 which is dependent on bacterial TTSS but independent of 
Toll-like receptors (TLRs). Using HEK293T cell line which is devoid of any TLR, we 
confirmed that indeed B. pseudomallei TTSS is involved in eliciting IL-8 independent of 
TLR. This process requires bacterial internalization and is not dependent on intracellular 
pathogen receognition receptor (PRR), NOD1 or NOD2. Bacterial TTSS is also required 
to activate nuclear factor-kappa B (NF-κB) and mitogen activated protein kinases 
(MAPK) such as Jun N-terminal kinase (JNK) although the latter plays a more crucial 
role in IL-8 induction. Furthermore, we show that B. pseudomallei can activate TLR2, 4 
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and 5 but the activation level is lower compared to a TTSS deficient mutant. This implies 
that the bacteria can suppress TLR-induced NF-κB activation partially through the TTSS. 
Our preliminary results suggest that TTSS-dependent suppression is probably at the level 
of p65/NF-κB although there is a possibility of B. pseudomallei targeting other 
intermediates in TLR signaling given that TTSS is not the sole contributor to the 
suppression. This is the first study to describe how B. pseudomallei TTSS modulate 
components in the innate immunity. Identification of bacterial effectors and the 
underlying mechanisms could shed light on pathogenicity of the bacteria in disease.  
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1.1 An overview of  the innate immune system 
Innate immunity is the most ancient immune response that exists in all multicellular 
organisms. Upon invasion by microbes, innate defense mechanism is activated very 
rapidly before the development of adaptive immune responses and thus, they serve as the 
first line of defense against infection. Broadly defined, the innate immune system 
includes all aspects of the host defense mechanisms that are encoded in the germ-line 
genes of the host and these include physical, chemical and microbiological components. 
Physical aspect would include epithelial cell layers lining the skin as well as the 
respiratory, gastrointestinal, and genitourinary tracts. These epithelial layers express cell-
cell contacts such as tight junction providing a barrier between the microbes in the 
external environment and host tissue. The secreted mucus on top of epithelial layers 
provides another form of protection as the mucus traps the pathogens which are then 
removed by the action of cilia. Chemical and microbiological aspects include 
complement proteins and antimicrobial peptides such as defensins that are constantly 
present in biologic fluids. Activation of complement such as C3b marks the bacteria or 
infected cells as targets for lysis and promotes opsonization and phagocytosis of microbes 
through binding to complement receptors on the surfaces of neutrophils and 
macrophages. On the other hand, molecules such as cytokines and chemokines are only 
released by cells once the cells are activated. Innate immune cells expressing PRR which 
recognize various pathogen-associated molecular patterns (PAMP) in microbes are 
capable of eliciting cytokine production. The various signaling cascades from the 
receptors eventually lead to NF-κB activation. Activation of transcription factors leads to 
release of cytokines such as tumour necrosis factor (TNF)-α and interleukin (IL)-1, which 
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could regulate function of cells, and chemokines could help recruit other inflammatory 
cells to the site of infection. Other important components of innate immunity are the 
immune cells such are phagocytic cells. Phagocytic cells, notably monocytes, 
macrophages and neutrophils engulf the microbes via the receptor-independent process of 
macropinocytosis or via receptors such as scavenger and mannose receptors. Once the 
microbes are inside, they are destroyed through the actions of proteolytic enzymes such 
as lysosomes, nitric oxide and reactive oxygen species. Other immune cells such as 
natural killer (NK) cells lyse virus-infected cells and eosinophils are particularly effective 
in protection against helminthes and other parasites. Dendritic cells (DC) represent 
another important innate cell and like macrophages, they are endowed with capability to 
engulf bacteria and at the same time, they function as antigen presenting cells capable of 
presenting processed bacterial antigen in combination with major histocompatibility 
complex (MHC) to initiate adaptive immune response. However, only dendritic cells but 
not macrophages are capable of initiating naïve T cells activation.  
 Though not antigen specific, the innate immune response is still able to alert the 
body of invading pathogens through the ability to recognize PAMP frequently found only 
in microbes and not self. It is now apparent that proper induction of innate immune 
system is crucial to influence the development of adaptive immunity. In fact, the adaptive 
response has co-opted many of the innate effector mechanisms to enhance its 
effectiveness. Thus, innate immune response is as important as adaptive immunity and 
these two arms of the immune response should be viewed as complementary and 
cooperative (reviewed by Parkin and Cohen, 2001; Beutler 2004; Blach-Olszewska 2005; 
Chaplin 2006). 
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1.2 NF-κB: Key regulator of cellular events 
NF-κB is a family of ubiquitous, evolutionary conserved transcription factor whose 
activity is rapidly induced in response to stimuli. NF-κB exists as heterogenous collection 
of dimeric proteins composed of various combinations of the Rel family members.  In 
mammalian cells, five Rel proteins belonging to two classes have been identified. One 
class includes RelA (p65), RelB and c-Rel that are synthesized as mature products and 
characterized by the presence of an N-terminal Rel homology domain (RHD). RHD 
contains the nuclear localization sequence (NLS) and is required for dimerization, DNA 
binding and interaction with the inhibitory protein, IκB. The C-terminus contains the 
transcription-activation domain (TAD) which enable them to activate gene expression 
(Bonizzi and Karin, 2004). The second class consists of the NF-κB1 (p50) and NF-κB2 
(p52) proteins, which are synthesized as the large precursors, p105 and p100, containing 
an N-terminal RHD and a C-terminal ankyrin repeat domain, requiring ubiquitin-
dependent proteolytic processing at the C-terminus (Fig. 1.2.1). All these NF-κB proteins 
dimerize to form homo- and heterodimers to either act as active or repressive complexes 
which in turn can differentially regulate target gene expression, hence the biological 
responses. For instance, since p50 and p52 do not contain the TAD, the p50 and p52 
homodimers repress transcription, unless they are bound to a protein containing a TAD, 
such as Bcl-3. Alternatively, p50 and p52 can act as transcriptional activating dimers by 
forming heterodimers with any Rel family members. However, in most cells, the 
predominant form is a heterodimer composed of p50 and RelA subunits (Ghosh et al., 
1998). 
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 Figure 1.2.1 Structure of NF-κB proteins and their regulators. (A) NF-κB proteins 
contain a well-conserved N-terminal, Rel-homology domain (RHD), which includes 
DNA binding and dimerization domains, and a nuclear localization signal (NLS) in 
addition to the RHD. On the other hand, p105 and p100 contain a glycine-rich hinge 
region (GGG) followed by C-terminal ankyrin (Ank) repeats that are also present in the 
IκB family of protein. (B)  IκB protein contains conserved ankyrin repeat motifs that are 
essential for IκB activity and mediate binding to the RHD. p105 and p100 are the 
precursors for p50 and p52, respectively. Figure is adapted from Bonizzi and Karin, 
2004. (Reproduced with permission from Elsevier Limited) 
 23
 In non-stimulated cells, NF-κB dimers are sequestered in the cytoplasm through 
interaction with inhibitory proteins, the IκB.  In response to cell stimulation, IκB is 
phosphorylated by protein kinase, the IκB kinase (IKK). Phosphorylated IκB are 
ubiquitinated by a specific E3 ubiquitination ligase complex which target them for rapid 
degradation by the 26S proteasome. Freed NF-κB dimers translocate into the nucleus to 
activate transcription of various genes. The canonical pathway of NF-кB activation 
involves the IKK complex consisting of two catalytically active kinases namely IKKα 
and IKKβ, and a regulatory protein IKKγ (Nemo) in which IKKβ and Nemo are 
necessary for activation of complexes such as p50/RelA. Conversely, the non-canonical 
pathway is induced in response to stimuli such as BAFF, CD40 etc.  In the normal state, 
RelB-p52 complexes are retained in cytoplasm as RelB-p100 precursor complexes 
because of the presence of C-terminal domain containing ankyrin repeats of p100. These 
repeats are homologous to those present in IκB and are required for repression of RelB-
dependent transcription. The processing of p100 and release of RelB-p52 complex relies 
on NF-κB-inducing kinase (NIK) and IKKα.  NIK mediates site specific phosphoryation 
and ubiquitination of p100 which is also dependent on IKKα. However, the exact 
mechanisms on how IKKα facilitates this process remain to be determined (Fig. 1.2.2) 
(reviewed by Liang et al., 2004; Yamamoto and Gaynor, 2004). 
The most well-known functions of NF-κB is in the activation of host immune and 
inflammatory responses. These include a plethora of cytokines, chemokines, 
antimicrobial peptides, inducible form of nitric oxide synthase (iNOS), receptors and 
adhesins for PMN transmigration, receptors for immune recognition such as MHC 
molecules as well as proteins involved in antigen presentation (Cammano and Hunter, 
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2002; Gaynor and Yamamoto, 2004; Liang et al., 2004). Beyond the control of immune 
response, NF-κB is also involved in cell proliferation and survival. NF-κB activates the 
expression of positive regulator of the cell cycle such as cyclin D1 and c-myc. On the 
other hand, NF-κB enhances cell survival by switching on genes that dampen pro-
apoptotic signals such as a member of Bcl2 family and cellular inhibitors of apoptosis (c-
IAP) (Gaynor and Yamamoto, 2004).  Considering the number of genes regulated by NF-
κB, it is no wonder that NF-κB serves as key regulator of cellular events in the host. 
 
 
Figure 1.2.2 Canonical and non-canonical NF-κB pathways. The figure on the left 
illustrates the steps involved in the activation of the classical NF-κB pathway, and the 
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right illustrates the alternative NF-κB pathway. Figure is adapted from Gilmore, 2006. 
(Reproduced with permission from Nature Publishing Group) 
 
1.3 NF-κB activation pathways 
NF-κB can be activated by many stimuli. All these stimuli initiate different signal 
transduction pathways but converge on the IKK signalosome complex contributing to 
NF-κB activation. The most common activators are through TLR pathways whereby 
pathogen products are recognized by extracellularly located TLRs. In the absent of TLRs, 
other host receptors are also capable of activating NF-κB which would be discussed in 
following sections. Other stimuli known for NF-κB activation include growth factors, 
mitogen and stress signals.  
 
1.3.1 Toll like receptors pathways 
TLRs are one of the most important receptors in innate immunity known to contribute to 
NF-κB activation. Toll was initially discovered in Drosophila melanogaster to play a role 
in dorsoventral patterning during embryonic development (Hashimoto et al., 1988). 
Subsequently, they have also been implicated in defense against fungi (Lemaitre et al., 
1996) and Gram-positive bacterial infections (Khush and Lemaitre, 2000). TLRs are 
evolutionary conserved and similar genes or gene products were also identified in 
invertebrates such as Caenorhabditis elegans and Anopheles gambiae as well as in plants 
and mammals. So far, eleven members of the TLR family have been identified in 
humans. Each of the TLRs recognizes distinct PAMPs (Akira and Takeda, 2004) and 
recognition of heat-shock proteins is likely due to contamination. TLR 1, 2, 4, 5, and 6 
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are located on the cell surface, primarily in recognition of bacterial components. 
Examples of such interactions include TLR4 which recognizes lipid A moiety of bacterial 
lipopolysaccharide (LPS), TLR2 recognizes peptidoglycan in addition to lipoproteins and 
TLR5 recognizes flagellin, a protein component of bacterial flagella (Hayashi et al., 
2001; Akira et al., 2006). Intracellularly located TLR3, 7, 8 and 9 are mainly responsible 
for recognition of viral products and bacterial DNA (Fig. 1.3.1). In addition, these TLRs 
can collaborate with other TLRs or with non-TLR receptors to further diversify its 
recognition potential and subsequent modulation of immune response against specific 
pathogens (Beutler et al., 2006; Lee and Kim, 2007).  
 
 27
 Figure 1.3.1 Toll-like receptors and their ligands.  ND = not determined. Profilin is the 
ligand for TLR11 (Lauw et al., 2005). * It is possible that these ligand preparations are 
contaminated with LPS and or other potent microbial components. Figure is adapted from 
Akira and Takeda, 2004. (Reproduced with permission from Nature Publishing Group) 
 
TLRs are type one transmembrane proteins with several domains; the leucine rich 
repeats at the amino terminal which are responsible for recognition of PAMPs and act as 
binding sites for coreceptors, a single transmembrane domain and  a cytoplasmic Toll-
interleukin 1 receptor (TIR) domain, where the assembly  of an active signaling complex 
occurs. All the TLRs share similar pathways of intracellular signaling, presented in 
Figure 1.3.2. The engagement of TLRs by PAMPs triggers the association of receptor 
with adapters containing TIR domain including myeloid differentiation factor 88 
(MyD88), TIRAP (MAL), TRIF (TICAM1) and TRAM (TICAM2) (Akira and Takeda, 
2004). MyD88 is utilized by all TLRs, with exception of TLR3; TIRAP (MAL) is used 
by TLR2 and TLR4; TRIF is used by TLR3 and TLR4 and TRAM is used by TLR4 only 
(Kawaii and Akira, 2006). TLR2 and TLR4 require TIRAP to bridge MyD88 to the 
receptor (Fitzgerald et al., 2001; Horng et al. 2002; Yamamoto et al., 2002); however, it 
is believed that other MyD88-utilizing TLRs directly recruit MyD88. This association 
further recruits members of the IL-1 receptor-associated kinase (IRAK) family; IRAK1 
and IRAK4, through association of the death domain (DD). Phosphorylated IRAKs 
associate with TNF receptor-associated factor (TRAF) 6.  TRAF6 serves as an E3 
ubiquitin ligase, together with an E2 ubiquitin-conjugating enzyme complex, it 
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ubiquitinates itself and IкB kinase (IKKγ). The ubiquitinated TRAF6 associates with 
TGFβ-activated kinase 1 (TAK1) together with its coactivators TAK-binding protein 
(TAB-1 and TAB-2). This mediates the activation of TAK1, a mitogen-activated protein 
(MAP) kinase kinase kinase (MAP3K) which leads to the activation of transcription 
factor NF-κB through the canonical IKK complex.  This pathway results in the 
expression of inflammatory cytokine genes. TAK1 is also involved in the activation of 
MAP kinases such as JNK and p38, which in turn activates activation protein (AP) -1 and 
subsequently regulates the inflammatory cytokine expression (reviewed by Wang et al., 
2001; Sato et al., 2005; Lee and Kim, 2007). 
On the other hand, TRIF and TRAM are adaptors required only for TLR3 and TLR4 
signaling resulting in activation of the transcription factor IFN regulatory factor 3 (IRF3). 
However, it has been shown recently in TLR3 and TLR4 signaling, TRIF through 
interaction with receptor-interacting protein-1 (RIP1) is required for subsequent NF-κB 
activation but not for IRF3 activation (Meylan et al., 2004; Cusson-Hermance et al., 
2005). Further studies show that this activation can be dependent or independent of 
TRAF6 depending on cell type specificity. For instance, TRAF6-TRIF interaction is 
indispensable for activation of NF-κB activation but not IRF-3 upon stimulation in 
fibroblasts. However, TRAF6 is not essential for such activation in macrophages (Gohda 
et al., 2004; Jiang et al., 2004).  
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 Figure 1.3.2 The TLR signaling pathway. All TLRs except TLR3 utilize MyD88 to 
transduce the signaling pathway leading to NF-κB activation. This pathway is also shared 
by IL-1R. TRIF adaptor activated by TLR3 and TLR4 has also been implicated in late 
NF-κB activation. Only TLR2 and TLR4 utilize TIRAP/Mal, TLR3 and TLR4 utilize 
TRIF and TRAM is only recruited by TLR4. Refer to text for explanation. Figure is 
adapted from Akira et al., 2006. (Reproduced with permission from Elsevier Limited) 
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1.3.2 Toll-like receptor-independent pathways 
Apart from the TLR dependent induction of NF-κB, cytoplasmic sensing of bacterial 
PAMPs mediated by NOD1 and NOD2 receptors which belong to the NOD-Like 
Receptor (NLR) family also induces NF-κB. NOD1 senses a peptidoglycan motif 
containing a diaminopimelate-containing N-acetylglucosamine-N-acetylmuramic acid 
tripeptide found mainly in Gram-negative but not Gram-positive bacteria (Girardin et al., 
2003a). On the contrary, NOD2 recognizes another peptidoglycan motif, muramyl 
dipeptide (MDP) found in both Gram-positive and Gram negative organisms (Girardin et 
al. 2003b; Inohara et al., 2003) 
The NOD proteins are characterized by three structural domains; a C-terminal LRR 
domain to sense a microbial motif, nucleotide binding site (NBS) required for the self-
oligomerization and activation as well as N-terminal effector motif, a caspase-activating 
and recruitment domain (CARD) (Kufer et al., 2005). Ligand recognition by NODs leads 
to receptor oligomerization and subsequent recruitment of RIP2 (also known as RICK) 
through homophilic CARD-CARD interaction (Inohara et al., 2000; Ogura et al., 2001). 
The activated RIP2 mediates ubiquitination of IKKγ responsible for NF-κB activation 
(Girardin et al., 2001) although the downstream signaling intermediates remain unknown. 
Some potential regulators of this pathway have been identified as TAK1, TRIP-6, GRIM-
19, and ERBIN although their modes of action remain to be determined (Werts et al., 
2006). Recently, it was shown that NOD signaling might share the same signaling 
intermediates as the TLR signaling except for the adaptors (Opitz et al., 2004). 
The induction of the transcription factor NF-кB can also be mediated by interaction 
of bacterial products with host receptors. For instance, Yersinia co-opt the mammalian 
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integrin receptor with its invasin protein to activate a signaling cascade involving Rac1, 
MAP kinases, activation of NF-κB, and subsequent production of chemokines (Schulte et 
al., 2000, Grassl et al., 2003). S. enterica serovar Typhimurium uses the TTSS effector 
SopE to directly induce nuclear responses in host cells (Hardt et al., 1998). It can also 
occur indirectly through host-produced pro-inflammatory cytokines such as IL-1 (Sims et 
al., 1993; Auron, 1998) and TNF-α (Vandenabeele et al., 1995; Baker and Reddy, 1998; 
Orlinick and Chao, 1998; Chen and Goeddel, 2002). IL-1 utilizes IL-1R which has an 
intracellular TIR domain, hence shares the same signaling pathway as TLR signaling 
(Kawai and Akira, 2007). On the other hand, TNF-α signals via trimerized TNF-α 
receptor (TNFR1), recruiting adaptor protein TNFR-associated death domain (TRADD), 
which in turn recruits TRAF2 and TRAF5. They then recruit the IKK complex directly 
(Devin et al., 2001) or indirectly through the serine/threonine kinase, RIP1. RIP1 can 
function in the absence of TRADD and has been shown to be essential adapter for TNF-
induced NF-κB activation to protect the cells from apoptosis (Hsu et al., 1996; Ting et 
al., 1996; Kelliher et al., 1998; Devin et al., 2000), Ubiquitinated RIP1 can recruit IKK 
by binding to NEMO (Zhang et al., 2000) but the activation of IKK requires TAK1 for 
subsequent downstream signaling cascade and NF-κB activation (Sato et al., 2000; Shim 
et al., 2005).  
 
1.4 Mitogen-activated protein kinase activation pathways 
MAPK are evolutionary conserved enzymes linking cell-surface receptors to important 
regulatory signaling targets in the cells. In mammals, four distinct groups of MAPKs are 
known: 1) Jun amino-terminal kinases (JNK1/2/3), 2) p38 proteins (p38α/β/γ/δ), 3) 
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extracellular signal-related kinases (ERK)-1/2 and 4) ERK5. These MAPK are regulated 
through three-tiered cascade composing of a MAPK, MAPK kinase and MAPKK kinase 
or MEK (ERK kinase) kinase. MAPK are activated by dual phosphorylation of conserved 
threonine and tyrosine residues within the loop by specific MAPK kinase: MKK3/6 for 
p38, MKK4/7 (JNKK1/2) for the JNKs, MEK1/2 for ERK1/2 and MEK5 for ERK. 
However, more than one MAPKK kinase activated by distinct stimuli can activate each 
of the MAPKK, thereby increasing the complexity of MAPK signaling. Activated MAPK 
are in turn inactivated by dephosphorylation by protein phosphatase (reviewed by Chang 
and Karin, 2001).  
A plethora of extracellular stimuli have been reported to mediate MAPK activation. 
Among the MAPK, only the activation pathway for ERK1/2 are fully defined. This 
activation pathway involves a variety of receptors such as receptor tyrosine kinase and G 
proteins that triggers activation of Ras-Raf followed by phosphorylation of MEK1/2 
(Wellbrock et al., 2004). Generally, ERK1/2 is associated with regulation of mitogenic 
and developmental function in cells in response to hormones and growth factors while 
JNK and p38 regulate stress and inflammatory responses. However, this dichotomy is an 
oversimplification because the actual role of each MAPK is highly cell type and context 
dependent. For instance, Yang et al. has demonstrated recently that Mycobacterium 
tuberculosis utilizes ERK1/2 but not p38 to regulate TNF-α production in monocytes and 
macrophages. This activation is independent of Ras or Raf but dependent on atypical 
protein kinase C (PKC) ζ that signal downstream of TLR2 (Yang et al., 2007). In contrast 
to ERK1/2, upstream signal transduction mechanisms for JNK and p38 cascade are less 
well understood. Ligation of TLR has been reported to activate p38 and JNK through 
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activation of MAP3K known as MEKK3/TAK (Huang et al., 2004). Other upstream 
stimuli including inflammatory cytokines such as IL-1 (Huang et al., 2004) and signaling 
through NOD (Opitz et al., 2006) and integrin receptors (Mainiero et al., 2000) have also 
been implicated. 
One of the most established functions of MAPK signaling is to regulate gene 
expression through activation of transcription factors in response to extracellular stimuli. 
In this scenario, MAPK functions inside the nucleus to modulate transcription factors 
before they are bound to DNA. For instance, JNKs phosphorylate Jun proteins, enhancing 
their ability to activate transcription. Most of MAPK phosphorylate the transcription 
factor Ets, which is required for induction of the fos gene. This product heterodimerizes 
with Jun protein to form AP1 complexes (Treisman, 1996). MAPK also function in the 
cytoplasm to regulate gene expression through post-transcriptional mechanisms such as 
in stabilizing mRNA expression (Winzen et al., 1999; Chen et al., 2000). This is 
achieved through activation of RNA-binding proteins, nucleolin and YB-1 by 
phosphorylation of JNK and p38 which can then bind to the 5’ untranslated region (Chen 
et al., 2000). In other instances, MAPK can phosphorylate numerous proteins such as 
skeletal proteins, kinases and other enzymes that influence cell survival, cell division and 
cell morphology (reviewed by Chang and Karin, 2001). 
 
1.5 Hijacking of NF-κB and MAPK activation pathways by microbial pathogens 
Pathogens which are able to interfere with the development of the innate immune system 
provide strong beneficial advantage to their own survival. Many upstream receptors in 
innate surveillance systems appear to converge at the downstream transcription factor, 
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NF-κB. It is now recognized that many pathogens utilize their TTSS to inject bacterial 
effectors into the target host and interfere with various aspects of the NF-κB pathway. 
One well-known example is Yersinia, which utilises YopJ to block NF-κB activation by 
acting as a deubiquitinase on TRAF2, TRAF6 and IкBα (Orth et al., 1999 and 2000; 
Zhou et al., 2005; Sweet et al., 2007). Aeromonas salmonicida AopP and Salmonella 
AvrA, which belong to the YopJ/Avr family, are mechanistically distinct from YopJ, 
suppressing NF-кB downstream of IKK activation. They also do not inhibit MAP kinases 
unlike YopJ (Collier-Hyams et al., 2002; Fehr et al., 2006). In another example, Vibrio 
parahaemolyticus uses TTSS protein VP1686 to physically associate with RelA/p65 NF-
κB heterodimer, affecting DNA binding activities in macrophages (Bhattacharjee et al., 
2006).  Pathogens such as Shigella flexneri may utilize more than one effector acting 
together to ensure that NF-кB-induced gene transcription is downregulated. Shigella 
effector OspG, serving as a protein kinase, is demonstrated to bind to various 
ubiquitinylated ubiquitin-conjugating enzymes, thus preventing phospho-IκB degradation 
and NF-κB activation. In addition, another effector OspF which is a dual phosphatase 
dephosphorylates MAPK in the nucleus, preventing histone H3 phosphorylation and 
hence accessibility of promoters to NF-κB (Kim et al., 2005; Arbibe et al., 2007). 
Subversion mechanisms can also occur by manipulating intermediates upstream of NF-
κB activation. Vaccinia virus blocks NF-κB through association of A54R with IRAK2 
and TRAF6, two key proteins in TLR signal transduction (Harte et al., 2003). An 
alternative immune evasion strategy adopted by some pathogens is by varying the 
acylation state of lipid A, hence affecting the responsiveness of bacterial LPS to TLR4. It 
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is reported that Salmonella deacylates lipid A reducing its ability to mediate TLR4-
induction of NF-κB activation (Kawasaki et al., 2004).  
Although inhibition of NF-κB is normally associated with inhibition of the immune 
response, some microbes have taken advantage of this pathway to enhance their survival. 
Yersinia pestis secretes a protein known as LcrV, which serves as a TLR2 agonist to 
activate NF-κB leading to IL-10 production. Anti-inflammatory cytokine IL-10 
suppresses the production of interferon (IFN)-γ and TNF-α, which are necessary for 
bacterial containment (Sing et al., 2002). On the other hand, Legionella pneumophila 
utilizes the Type four secretion system (Dot/Icm) to activate NF-κB, critical for 
promoting host cell survival and preventing termination of bacterial replication (Losick 
and Isberg, 2006). Increased activation of NF-κB also contributes to the progression of 
tissue damage, creating the opportunity for bacterial spreading. Shigella is known to 
sustain NF-κB activation through ligation with intracellular PRR (Phillpot et al., 2000). 
This contributes to the production of inflammatory mediators which is capable of 
disrupting the epithelial layer to ease bacteria penetration. Similarly, Helicobacter pylori 
uses Type four secretion system to directly activate p21-activated kinase 1 (PAK1), 
resulting in NF-κB activation which is presumably required to support the life cycle of 
this bacterium (Foryst-Ludwig and Naumann, 2000; Mori et al., 2001). Collectively, 
bacterial subsistence in the context of the host environment has driven them to evolve 
diverse strategies to either manipulate NF-κB or MAPK signaling pathways with the 




1.6 Burkholderia pseudomallei and its Type Three Secretion system  
Gram-negative Burkholderia pseudomallei is the causative agent of disease known as 
melioidosis, which was first described by Whitmore and Krishnaswami in postmortem 
examinations of Rangoon vagrants in 1912 (Whitmore and Krishnaswami, 1912). B. 
pseudomallei is a saprophytic, motile, facultative anaerobic and non-spore forming 
bacterium. It is a natural inhabitant of soil and surface water in areas of endemicity, 
which encompasses Southeast Asia and tropical Australia (Currie et al., 2000; 
Leelarasamee, 2000) although there is evidence that it may be endemic in Africa, the 
Indian subcontinent and Central and South America (Dance, 1991). B. pseudomallei 
possesses a huge genome, represented by two chromosomes of size 4.07Mb and 3.17Mb. 
The genome of this bacterium has been completely sequenced (Holden et al., 2004) and 
the fully annotated version is available in Genbank.  
B. pseudomallei exhibits broad tissue tropism and is capable of infecting and invading 
non-phagocytic cells such as epithelial cells (Harley et al., 1998) and phagocytic cells 
such as macrophages (Razak and Ismail, 1982; Pruksachartvuthi et al., 1990; Ulett et al., 
1998).   This might be contributed by many virulence factors which have been identified 
in B. pseudomallei over the years. B. pseudomallei possesses secreted virulence products 
such as protease, lipase, lechithinase and heat-labile toxin in addition to cell-associated 
products such as flagella, capsule, lipopolysaccharide and pili (Ashdown and Koehler, 
1990; Brett and Woods, 1996; Chua et al., 2003; Cheng and Currie 2005). Apart from 
that, quorum sensing in B. pseudomallei which uses N-acyl-homoserine lactones for the 
coordination of gene expression is reported to be necessary for virulence (Ulrich et al., 
2004). Mutation in genes encoding quorum sensing homologues leads to reduced 
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virulence and increase time of death in BALB/c mice (Ulrich et al., 2004). Moreover, 
quorum sensing homologues have also been reported to control regulation of 
metalloprotease (Valade et al., 2004) and secretion of exoproducts (Song et al., 2005), 
which might explain the requirement of quorum sensing for optimal virulence in the 
mouse model. 
Another recognized and crucial virulence determinant which contributes to B. 
pseudomallei survival and pathogenicity, is the bacterial TTSS. TTSS are specialized 
structures which translocate bacterial effectors into host cells in a temporal and spatially 
coordinated manner. This is achieved through an injectisome, a needle complex spanning 
outer and inner membranes of bacterial envelope resembles the flagellar hook basal body 
complex. The needle complex composed of three parts; the needle, the base and the 
export apparatus associated with the inner membrane of the base (reviewed by Galan, 
2001). While the injectisome is made up of approximately 20 genes which are highly 
conserved among different TTSS of distantly related bacteria, effector proteins injected 
through TTSS are much more diverse. There are three TTSS found in the complete 
sequence of B. pseudomallei genome (Winstanley et al., 1999; Rainbow et al., 2002; 
Holden et al., 2004). Two of them, TTSS1 and TTSS2 resemble that of Ralstonia, a plant 
pathogen (Attree and Attree, 2001). The third TTSS, named Burkholderia secretion 
apparatus (bsa) TTSS resembles the inv/mxi TTSS in Salmonella and Shigella (Attree and 
Attree, 2001; Stevens et al., 2002).  bsa TTSS is the only TTSS that is highly conserved 
in all B. pseudomallei and related B. mallei and B. thailandensis strains (Kim et al., 
2005b).  
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Injected TTSS effectors are shown to modulate various cellular host functions and 
most likely affect various stages of bacterial infection. B. pseudomallei mutants lacking 
BopE and BipD have impaired bacterial entry in epithelial cells (Steven et al., 2003). In 
addition, B. pseudomallei lacking components of TTSS is unable to escape from 
endocytic vacuoles and hence displays reduced capability to replicate inside macrophage 
cells (Steven et al., 2002). Another B. pseudomallei effector BipB has been shown to 
modulate the formation of multinucleated giant cells and is involved in cell to cell 
spreading (Suparak et al., 2005). Recently, bacterial TTSS is also reported to induce 
caspase-1 dependent cell death in macrophages and dendritic cells (Sun et al., 2005), 
probably through pore-formation in host cells although the participating effectors remain 
elusive.  The importance of bsa TTSS is further corroborated by studies using animal 
models. B. pseudomallei BipD mutant is attenuated following intranasal and 
intraperitoneal infection of BALB/c mice (Stevens et al., 2004) and bsa TTSS but not 
TTSS1/2 is further demonstrated to be required for full virulence in hamster model of B. 
pseudomallei infection (Warawa and Woods, 2005).  
 
1.7 Melioidosis 
Melioidosis is the infectious disease caused by Burkholderia pseudomallei.  The most 
common mode of B. pseudomallei infection occurs through inoculation of compromised 
surface tissues by contaminated soils and waters, although inhalation and aspiration of 
contaminated formites and ingestion of the organism have also been reported (Cheng and 
Currie, 2005; Wiersinga et al., 2006). Melioidosis has a broad spectrum of clinical 
presentations ranging from asymptomatic seroconversion, acute and chronic infection, 
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localized infection involving one organ to disseminated septicemia and even to septic 
shock (Leelarasamee and Bovornkitti, 1989; Leelarasamee, 2004). Severe septic 
melioidosis is usually associated with underlying diseases such as diabetes and chronic 
renal failure (Leelarasamee, 2004), although it sometimes occurs in previously healthy 
individuals (Chaowagul et al., 1989). One of the remarkable features of melioidosis is its 
capability for latency (May and Ricketts, 1975; Koponen et al., 1991) with the longest 
incubation periods recorded to be 62 years (Ngauy et al., 2005). Furthermore, relapse is 
common in patients despite treatment with appropriate antibiotics. B. pseudomallei is 
capable of infecting all the organs, although pathology occurs mainly in the lung, spleen 
and liver (Piggott and Hochholzer, 1970; Wong et al., 1995). 
Treatment of melioidosis proves to be very difficult even with early detection and 
intervention as B. pseudomallei is resistant to many of antibiotics including beta-lactams, 
aminoglycosides, macrolides and polymyxins (Chaowagul, 2000; White, 2003; Cheng 
and Currie, 2005). Prior to the use of antibiotics, the case fatality rate from apparent B. 
pseudomallei infection was 95 %. Even with vigorous appropriate antibiotics and 
supportive therapy, the mortality in patients with melioidosis septicemia is 40 % or 
greater (White et al., 1989). Moreover, B. pseudomallei infection can persist for decades 
as a chronic latent condition which may require prolonged periods of oral maintenance 
antibiotic and life-long follow up (Dance, 1991).  
While melioidosis is increasingly being recognized as a significant cause of morbidity 
and mortality in endemic regions, currently there are no effective vaccines for 
melioidosis. Studies employing various immunization approaches include the use of 
bacterial subunits such as LPS and capsular polysaccharide (Nelson et al., 2004), 
 40
flagellin, and bacterial DNA (Warawa and Woods, 2002) and the use of avirulent strains 
(Stevens et al., 2004) and auxotrophic mutants (Atkins et al., 2002). Mice inoculated with 
attenuated strain such as B. pseudomallei BipD mutant are partially protected from 
subsequent challenge with live bacteria (Stevens et al., 2004) but live attenuated vaccines 
are unlikely to be approved as potential human use. Another strategy is immunization 
using dendritic cells pulsed with heat-killed bacteria as delivery vector (Healey et al., 
2005). Although strong cellular immune responses are elicited, the antibody response is 
quite low. However, subsequent booster immunizations either with a second dose of 
dendritic cells or heat-killed bacteria are able to increase the immune response and 
protect the mice from a subsequent challenge with virulent B. pseudomallei. This could 
be a potential candidate vaccine as it stimulates both humoral and cell-mediated 
immunity which are required for effective bacterial clearance.  
 
1.8 Host defense in melioidosis 
The innate immune response is likely an important initial defense mechanism against B. 
pseudomallei infection. The failure of the immune response at this stage likely leads to 
acute form of the disease. Previous studies have established murine models of acute and 
chronic melioidosis.  In the inbred mouse models, BALB/c mice were reported to be 
more susceptible relative to C57BL/6 following the intravenous (Leakey et al., 1998; 
Hoppe et al., 1999) and intranasal routes (Liu et al., 2002) of infection. BALB/c mice 
died within days, characterized by overwhelming bacterial spreading in organs and blood 
and excessive organ inflammation and necrosis (Leakey et al., 1998; Hoppe et al., 1999). 
Although a higher level of proinflammatory cytokines such as TNF-α, IL-1β and IFN- γ 
 41
were detected at 1-2 days after infection in BALB/c than C57BL/6 mice, but they failed 
to contain the bacteria (Ulett et al., 2000; Liu et al., 2002). Previously, it has been shown 
that early IFN-γ is essential for resistance following intraperitoneal B. pseudomallei 
infection in mice. Depletion of IFN-γ by neutralizing antibodies results in early death of 
Taylor outbred mice, demonstrating the importance of IFN-γ for resistance in acute 
infection (Santanirand et al., 1999). This is not unusual given that IFN-γ is known to 
enhance microbicidal activity in macrophages (Utaisincharoen et al., 2001) and hence 
increases the B. pseudomallei killing efficacy in comparison to the unstimulated cells. 
Recently, it has been reported that overproduction of IFN-γ seen in the BALB/c mice was 
attributed to uncontrolled bacterial growth (Koo and Gan, 2006). Splenocytes from 
BALB/c mice were poorer in controlling bacterial growth compared to C57BL/6 mice 
(Koo and Gan, 2006). Furthermore, Breitbach et al. has shown that macrophages from 
BALB/c mice were not as responsive to IFN-γ stimulation to kill B. pseudomallei as the 
C57BL/6 mice (Breitbach et al., 2006). Apart from macrophages, Easton et al. has also 
demonstrated a protective role for neutrophils in early defense as depletion of neutrophils 
resulted in acute lethal infection in C57BL/6 mice. A corresponding decrease in IFN-γ, 
TNF-α and IL-6 of up to 98 % was observed which correlated well with disease severity 
(Easton et al., 2007). Notably, diabetes mellitus, a condition that predisposes individuals 
to melioidosis is associated with impaired neutrophil function (Suputtamongkol et al., 
1999; Calvet and Yoshikawa, 2001). Also, diabetic rats are reported to be more 
susceptible to infection leading to acute form of disease and rapid death. Although 
neutrophils can phagocytose B. pseudomallei, the killing mechanism through respiratory 
burst proves to be inefficient (Pruksachartvuthi et al., 1990; Egan and Gordon, 1996). 
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Additionally, B. pseudomallei is shown to resist a potent neutrophil antimicrobial peptide, 
defensin (Jones et al., 1996). Hence, it is likely that macrophages are better in bacterial 
containment but may be dependent on other cell types such as neutrophils to generate a 
moderate but controlled inflammation exhibited in C57BL/6. 
In contrast to BALB/c mice, C57BL/6 mice exhibited a chronic form of melioidosis 
where all the mice died only after 2-6 weeks of infection with a significantly higher level 
of IgA, IgG2a and IgM detected (Leakey et al., 1998). Detection of IgG2a indicated the 
involvement of cell-medicated immunity (CMI) as isotype switching is regulated by IFN-
γ which is derived from Th1 cells. Patients who recovered from melioidosis develop CMI 
as reflected by the significant amount of T cell activation and proliferation in response to 
B. pseudomallei antigens compared to that of the control group (Ketheesan et al., 2002). 
It is tempting to speculate that patients used in that study are able to recover because of 
the development of protective adaptive immunity. Additionally, asymptomatic 
seropositive individuals exhibited greater cell-mediated immunity as determined by the 
bacterial specific lymphocyte proliferation and IFN-γ production compared with patients 
with a history of clinical melioidosis (Barnes et al., 2004). The intracellular nature of B. 
pseudomallei together with its capability to persist in the intracellular environment 
highlight the need to generate CMI, particularly CD8+ T cells to achieve effective 
bacterial clearance to prevent latent form of melioidosis and reactivation to occur. So far, 
insights derived from immunization studies indicate that protection elicited by live 
attenuated mutants against virulent bacteria is mediated by CD4+ but not CD8+ T cells 
(Haque et al., 2006). However, more studies are required before a definitive conclusion 
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can be reached about the relative roles played by CD4+ and CD8+ T cell in mediating 
immunity specific to various stages of B. pseudomallei infection.   
 
1.9 Evasion of innate immunity by Burkholderia pseudomallei 
Given the importance of innate immune response to control early stages of bacterial 
invasion, many bacterial pathogens including B. pseudomallei have evolved ways to 
circumvent this defense mechanism. This is exemplified by the unique characteristics of 
B. pseudomallei lipopolysaccharide (LPS). In addition to the long-fatty acids, 3-
hydroxyhexadecanoic acid as amide-linked fatty acids, LPS also consists of an unusual 
acid-stable inner core region attached to lipid A (Kawahara et al., 1992). B. pseudomallei 
LPS is found to be less pyrogenic in rabbits and in galactosamine-sensitized mice than 
LPS from Salmonella species (Matsuura et al., 1996). In another report, the LPS seems 
less able to induce TNF-α and nitric oxide production in macrophages compared with that 
of Salmonella and E. coli (Utaisincharoen et al., 2000) Correspondingly, slower 
phosphorylation of p38 is also observed, most likely due to the unusual structure of LPS 
which renders it from being fully recognized by receptor that recognize lipid A moiety of 
LPS, TLR4. Interestingly, low production of IL-8 is also noted in epithelial cell lines 
infected with whole bacterium, B. pseudomallei in comparison to S. typhi with a 
corresponding slower degree of I-κB degradation (Utaisincharoen et al., 2004). Similarly, 
it has been reported that macrophages infected with whole B. pseudomallei also display 
poor expression of inducible nitric oxide synthase (iNOS) and poor induction of TNF-α 
(Utaisincharoen et al., 2001). This phenomenon may not be due solely to LPS structure 
but could also be the result of B. pseudomallei manipulating host signaling. B. 
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pseudomallei is shown to induce the expression of two negative regulators, suppressor of 
cytokine signaling 3 (SOCS3) and cytokine-inducible Src homology 2-containing protein 
(CIS), which directly correlate with a decrease of Y701-STAT-1 phosphorylation 
induced by IFN-γ. The reduction of IFN-γ signaling is associated with the failure of the 
B. pseudomallei-infected cells to activate iNOS expression, thus limiting its capacity to 
kill intracellular B. pseudomallei (Ekchariyawat et al., 2005).  
B. pseudomallei is also able to invade, survive and replicate in epithelial (Jones et al., 
1996) and phagocytic cells (Pruksachartvuthi, 1990). TTSS proteins, BopE and BipD, are 
shown to facilitate bacterial entry (Stevens et al., 2003). Moreover, B. pseudomallei bipD 
mutants are attenuated in the intraperitoneal and intranasal challenge of BALB/c mice 
with corresponding impairment of bacterial replication in liver and spleen (Stevens et al., 
2004). Following internalization in macrophages, B. pseudomallei is able to escape from 
the endocytic vacuoles into the cytoplasm, thus allowing it to spread from cell to cell by 
forming membrane protrusions and actin tails (Kespichayawattana et al. 2000; Stevens et 
al., 2002 and 2005). Poor induction of iNOS in macrophages by B. pseudomallei 
(Ekchariyawat et al., 2005) presumably would also interfere with a robust respiratory 
burst, allowing the bacteria to survive intracellularly. Moreover, B. pseudomallei is 
capable of inducing caspase1-dependent death in macrophages and dendritic cells (Sun et 
al., 2005). This death resembles oncosis and is dependent on bsa TTSS similar to those 
described for Salmonella and Shigella species.  
In the chemical aspect of innate immunity, B. pseudomallei is able to resist host 
antimicrobial peptides such as protamine and defensins (Jones et al., 1996). B. 
pseudomallei also possesses a capsular polysaccharide that interfere with deposition of 
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complement factor C3b, hence, rendering it resistant to lysis by human serum 
(Reckseidler-Zenteno et al., 2005).  All in all, B. pseudomallei seems to be able to evade 
different levels of innate immunity from initial recognition of bacterial components to 
manipulation of the immune cell function and subsequent effector mechanisms. 
 
1.10 Rationale and aims of the study 
The roles of epithelial cells in innate immune response are not limited to being as static 
mechanical hurdles to impede pathogen invasion but include the ability to elicit effectors 
in response to pathogens. Many studies have demonstrated that B. pseudomallei interact 
with epithelial cells, but so far all these studies are conducted using non-polarized cells 
(Jones et al., 1996; Harley et al., 1998; Utaisincharoen et al., 2004). In this study, we 
sought to use polarized epithelial cells which better resemble the in vivo condition and are 
mechanically and biochemically distinct from non-polarized epithelial cells 
(Kazmierczak et al., 2001; Berkes et al., 2003). This can give us clearer insights on how 
B. pseudomallei infects epithelial cells and in turn how epithelial cells are activated in 
response to infection. Epithelial cells need to sense pathogen, and translate this early 
recognition to intracellular signaling that converge at NF-κB to initiate subsequent 
defense response in order to fend off pathogen. One of the well studied signaling 
receptors capable of doing so is the TLRs. However, due to the localization of epithelium 
as interface separating extracellular from intracellular milieu and epithelium is constantly 
exposed to non-pathogenic microbes, the sensing receptors and mechanisms may vary 
from other innate immune cells. Epithelial cells are poorly responsive to TLR agonists, 
easily explained by the lack of accessory molecules and compartmentalization and 
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intracellular anatomical localization of some TLRs such as TLR4 and TLR5 (Abreu et 
al., 2001; Gewirtz et al., 2001; Melmed et al., 2003). Moreover, studies have also shown 
that there are sensing mechanisms other than TLRs in epithelial cells (Travassos et al., 
2005; Zilbauer et al., 2007). Although several reports indicate capability of B. 
pseudomallei in inducing cytokines in epithelial cells and other cell types 
(Pruksachartvuthi, 1990; Utaisincharoen et al., 2004), the participating receptors remain 
elusive. Herein this study, we described B. pseudomallei interaction with TLRs. Aside 
from TLRs, we also elucidate the mechanisms underlying B. pseudomallei-mediated 
other non-TLR leading to NF-κB activation and IL-8 production in epithelial cells.  
Given that B. pseudomallei TTSS has been implicated in pathogenicity and virulence, the 
contribution of the bsa TTSS is also being examined in the modulation in B. 
pseudomallei-host interactions.  
 
Specific objectives of this thesis include: 
 
1) Examine the interaction of Burkholderia pseudomallei with polarized epithelial 
cells, Caco-2 and contribution of bsa TTSS in this process. 
2) Elucidate the mechanisms of Toll-like receptor-independent but bsa TTSS 
dependent NF-κB activation and IL-8 production by Burkholderia pseudomallei 
in epithelial cells. 
3) Investigate the interaction of Burkholderia pseudomallei with Toll-like receptors 
















































Epithelial cells that line the mucosal surfaces act as an important mechanical barrier that 
separates the host’s internal milieu from the external environment. Most microbial 
pathogens have to surmount this epithelial barrier in order to establish infection and cause 
disease. Invasive microbes such as Salmonella and Shigella induce their own uptake into 
epithelial cells by engaging different host receptors and exploiting host signaling 
pathways (Cossart and Sansonetti, 2004). However, the roles of epithelial cell layers are 
not restricted to static barriers but include eliciting defense response upon microbial 
invasion. These responses include proliferation of epithelial cells, increased mucus 
secretion and release of physiologic mediators as well as cytokines and chemokines. By 
upregulating surface expression of adhesins such as intercellular adhesion molecule-1 
(ICAM-1) and by producing various cytokines and chemokines, they help in recruitment 
of polymorphonuclear (PMN) cells to the site of infection. The various cytokines also act 
on other immune cells such as macrophages, dendritic cells, lymphocytes. Chemokines 
such as CCL20 may recruit dendritic cells or neutrophils respectively which may have an 
autocrine/paracrine function on neighbouring intestinal epithelial or other mucosal cells. 
Hence, epithelial layer is an integral component of a communication network by acting as 
the signal provider for the onset of inflammatory response early in infection as well as the 
subsequent mucosal immune response by influencing cells in the adjacent and underlying 
mucosa. 
Most B. pseudomallei infections in humans are known to occur through 
inoculation of compromised surface tissues by contaminated soils and waters but 
infection through inhalation of contaminated fomites and ingestion of organisms have 
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also been reported (Leelarasammee and Bovornkitti, 1989). The establishment of the 
intranasal route of infection in animal models that mimics human disease (Liu et al., 
2002) further demonstrates the importance of understanding mucosal infection. In the 
scenario where mucosal infection occurs, the mucosal epithelia would be the first to 
contact bacterial pathogens. Successful elimination of pathogens depends on rapid 
recognition of the invading pathogens which is crucial for the development of the 
immune against the bacterium.  
Although studies have been done on interaction of B. pseudomallei with epithelial 
cells in cultured epithelial cells, little is known about how the bacteria interact with 
polarized mucosal epithelial cells. Polarized epithelial cells are different from non-
polarized cells as these cells have developed distinct apical and basolateral surfaces that 
are biochemically distinct and are essential for epithelial cell functions. These apical and 
basolateral domains are separated by the circumferential tight junctions, which are 
important in maintaining epithelial cell surface polarity as well as providing high 
resistance intercellular seals to prevent entry of pathogens (Kazmierczak et al., 2001; 
Berkes et al., 2003). Moreover, there is emerging evidence showing that bacterial 
interactions with polarized epithelial cells have different molecular requirements as 
compared to interactions with non-polarized cells. For example, Rac1 is involved in 
apical internalization of Salmonella typhimurium in polarized epithelial cells whereas in 
non-polarized cells, the GTPase Cdc42 modulates its entry (Criss et al., 2001). Likewise, 
both Rac1 and Cdc42 are involved in basolateral exocytosis and secretion of IL-8 
induced by Salmonella typhimurium in polarized epithelial cells while this is not 
observed in non-polarized epithelial cells (Hobert et al., 2002). Thus, there may be 
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important differences between polarized versus non-polarized epithelial cells and ideally, 
studies modeling how bacteria interact with the primary defensive barrier during an in 
vivo mucosal infection should employ polarized epithelial cells. 
Studies have shown that B. pseudomallei could invade, replicate and induce IL-8 
in non-polarized epithelial cells (Jones et al., 1996; Harley et al., 1998; Utaisincharoen et 
al., 2004).  In this study, we use polarizable colon carcinoma cell line (Caco-2) to 
investigate how B. pseudomallei interacts with polarized mucosal epithelial cells to 
establish infection and how the host cells respond to the pathogen. Given that much 
attention has been directed at understanding the function TTSS, the contribution of the 
bsa TTSS is also being examined for its modulation in the host-pathogen interactions.  
The bsaQ gene is the homolog of the Salmonella invA gene, which encodes a conserved 
component of the base of the TTSS apparatus.  In Salmonella, deletion of invA results in 
a defective TTSS due to the collapse of the needle complex (Stevens et al., 2002). We 
had created a null TTSS mutant, bsaQ mutant, which is defective in secreting effectors 
such as BopE and translocator BipD (Sun et al., 2005; Hii et al., 2008). 
 
2.2 MATERIALS AND METHODS 
 
2.2.1 Bacterial strains 
The virulent B. pseudomallei strain, KHW, was isolated from a Singapore national 
serviceman who died from melioidosis (Sun et al., 2005) and used throughout the study. 
The fliC (Chua et al., 2003) and bsaQ (Sun et al., 2005) mutants are generated from wild-
type KHW as described previously. Burkholderia thailandensis (ATCC 700388) was 
obtained from the American Type Culture Collection and the Salmonella strains were 
kind gifts from Professor Jimmy Kwang (Temasek Life Sciences Laboratory, Singapore). 
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To prepare mid-log phase bacteria, 5 mL Luria Bertani (LB) medium was inoculated with 
250 μL overnight culture and allowed to grow for 3 hours with constant agitation. 
 
2.2.2 Cell lines 
Caco-2 cell line (ATCC HTB-37) is derived from human colon carcinoma which has the 
epithelial-like appearance and expresses the characteristics of polarized epithelial cells. 
A549 is the lung epithelium cell line which does not express the characteristic of 
polarized epithelial cells (ATCC CCL-185). HEK293T cell line (ATCC CRL-11268) is 
generated from transformed human embryonic kidney cells. A549 and HEK293T cell 
lines were cultured and maintained in DMEM medium (Sigma, St. Louis, MO) 
supplemented with 10 % heat-inactivated fetal bovine serum, FBS (Biological Industries, 
Kibbutz Beit Haemek, Israel), 2 mM L-glutamine (Sigma) and a mixture of 100 U/ml 
penicillin and 0.1 mg/ml streptomycin (Sigma). Caco-2 cell line was grown in complete 
Modified Dulbecco’s Eagle’s MEM (Gibco BRL, Gaithersburg, MD) supplemented with 
20 % FBS and 1 mM pyruvate (Sigma). Throughout the study, the cells were incubated at 
37°C in a humidified incubator in the presence of 5 % CO2. 
 
2.2.3 Recombinant flagellin protein purification 
The full length of B. pseudomallei flagellin gene with a 6x-Histidine tag at the N-
terminus was cloned into the expression vector pQE-30 (QIAGEN, Hilden, Germany), 
and the plasmid was transformed into E.coli M15 cells. The log-phase bacterial culture 
grown in the presence of ampicillin (100 μg/ml) and kanamycin (25 μg/ml) was induced 
by 1 mM isopropyl-β-D18 thiogalactopyranoside (Promega) for 3 hours when the culture 
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reached an OD600 of 0.6. The cell pellet was resuspended in 20 ml of Buffer B (100 mM 
NaH2PO4, 10 mM Tris HCl, 8 M urea at pH 8) and sonicated. Flagellin in the clarified 
supernatant was purified by incubating with Ni-NTA resin (CLONTECH laboratories 
Inc., CA, USA). The tube was rotated at 4°C for 1 hour before the content was loaded to 
a 20 ml column. The column was washed with 10 times bed volume of Buffer B, 
followed by Buffer C (Buffer B at pH 6.3 with and without 0.5 % of polymyxin B). The 
protein was eluted and the concentration in each fraction determined using Bradford 
assay (Bio-rad, Hercules, CA, USA). The purity of the fractions was determined using 10 
% SDS-PAGE. Fractions containing flagellin only were combined and dialysed before 
concentrated to the required final protein concentration in PBS. 
 
2.2.4 Caco-2 transwell culture system and electrical resistance measurements 
Caco-2 cells were seeded at a density of ~1 × 105 cells on the upper surface of vertical 
transwell filter units (Fig. 5.2.1) (Costar, Corning, NY). The media from the upper and 
lower compartments were changed every two days until confluency was reached at about 
day 10. The TEER was measured with a Millicell-ERS apparatus (Millipore, Bedford, 
MA). The cells were considered confluent when a TEER of 330 Ω/cm2 was achieved 





2.2.5 Invasion and replication assay 
Caco-2 and A549 cells were seeded at 2.5 × 105 cells per well in 12-well plates and 
incubated overnight at 37°C with 5 % CO2. On the day of infection, the culture medium 
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was removed and replaced with antibiotic-free medium, and the mid-log phase bacteria 
were added to each well to give a multiplicity of infection (MOI) of approximately 30 
bacteria per cell. Two hours after infection, extracellular bacteria were inactivated by 
addition of 40 µg/ml of tetracycline (Sigma). Tetracycline was used instead of kanamycin 
as our bacterial mutants were generated by insertion of a kanamycin cassette. To monitor 
intracellular replication of bacteria, extracellular bacteria were washed three times with 
PBS, lysed with 0.1 % Triton-X and enumerated by plating in serial dilutions after 4 and 
24 hours of incubation. 
 
2.2.6 Assessment of transepithelial electrical resistance (TEER) reduction 
The experiments were performed using Caco-2 cells in transwell culture system when the 
electrical resistance of the cells reached about 330 Ω/cm2 or higher, which usually 
occurred in 10 to 14 days. Before the experiment, the filters were washed twice and 
replaced with antibiotic-free medium. 2 × 108 bacteria were added to the upper chamber; 
this inoculum is consistent with that used by others (Rescigno et al., 2001). Uninfected 
cells were used as negative controls. TEER was monitored at the beginning and every 2 
hours thereafter until 17 hours after infection. Reduction of TEER is expressed as 
percentage change from the initial TEER before infection. 
 
2.2.7 Assessment of cell death 
Cells were seeded and infected as in 2.2.6. To measure cell lysis, supernatant from the 
apical and basal compartments of the transwell were assessed for lactate dehydrogenase 
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(LDH) levels using the cytotoxicity detection kit (Roche Diagnostics, Indianapolis, IN) 
and assays were performed according to manufacturer’s instructions.  
Caco-2 and A549 cells were seeded at 1 × 106 cells per well in 6-well plate and 
incubated overnight. B. pseudomallei strain KHW and bsaQ mutant at MOI of 100:1 
were used for infection in antibiotics-free medium. After 2 hours, the cells were washed 
and further incubated for 34 hours in the presence of 40 μg/ml tetracycline. At different 
time intervals, the cells were harvested and death was determined by TUNEL Assay 
(Clontech, Palo Alto, CA) using flow cytometry following manufacturer’s instructions. 
Uninfected and UV-treated cells were used as negative and positive controls, 
respectively. 
 
2.2.8 Detection of IL-8 by ELISA 
 Caco-2 cells in the transwell system were infected in the apical and basal chambers with 
2 × 107 (MOI=10:1) or 2 × 108 (MOI=100:1) colony forming unit (CFU) in antibiotics-
free medium. Two hours after infection, 40 μg/ml of tetracycline was added. Supernatant 
were collected from apical and basal chambers at different time-points and assayed for 
IL-8 production by ELISA (Bender MedSystems, Vienna, Austria) according to 
manufacturer’s instructions. Uninfected cells were included in each time-point as a 
negative control. bsaQ and fliC mutants as well as the flagellin protein and LPS were 





2.2.9 Detection of NF-κB activation 
NF-κB activation was measured as previously described (Zhang et al., 2002).  After 2.5 x 
105 of HEK293T cells were seeded for 24 hours, the cells were co-transfected with two 
luciferase reporter plasmids; p5xNF-κB-luc (Stratagene, La Jolla, CA), pRL-CMV 
(Promega, Madison, WI) and with human TLR5 (Zhang et al., 2002) using the 
GenePORTER 2 reagent (Gene Therapy System, La Jolla, CA). As negative controls, the 
cells were transfected with the pcDNA3.1 vector. The cells were stimulated with flagellin 
at desired concentration for 7 hours before NF-κB activation was assayed. The cells were 
lysed with passive lysis buffer (Promega), and the lysate were diluted 50X with water. 
The luciferase expression was then determined with 2 μl of diluted lysate in 96-well 
white plates using the Dual Luciferase Assay Kit (Promega) with detection on the Centro 
LB 960 luminometer (Berthold Technologies).  NF-κB activation was expressed as a 
ratio of Firefly luciferase activity over Renilla luciferase activity. 
 
2.3 RESULTS 
2.3.1 Invasion and intracellular replication of B. pseudomallei in epithelial cells. 
B. pseudomallei could invade and replicate in non-phagocytic cells such as epithelial 
cells (Jones et al., 1996; Harley et al., 1998). We determined the invasion and replication 
of B. pseudomallei strain KHW in polarized Caco-2 cells. The bsaQ mutant was also 
examined to see if it was attenuated in the capacity to invade and replicate in epithelial 
cells. Cells were infected with MOI of 30 bacteria per cell. Figure 2.1.1A shows similar 
numbers of intracellular wild-type and mutant bacteria at 4 and 24 hours of infection in 
polarized Caco-2 cells. Our result on the ability of bsaQ mutant to invade polarized cells 
is somewhat inconsistent with the recent report by Stevens et al. who found that B. 
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pseudomallei Type Three secreted protein, BopE, is required for bacterial invasion of 
non-polarized epithelial cells (Stevens et al., 2003). To exclude the possibility that this 
discrepancy is due to cell type specificity, we tested and found that bsaQ mutant could 
invade and replicate as well as the wild-type bacteria at 24 hours after infection of non-
polarized A549 cells (Fig. 2.1.1B). 
 
 57
Figure 2.1.1 Invasion and intracellular replication of B. pseudomallei, KHW and 
bsaQ mutant in polarized Caco-2 cells and non-polarized A549 epithelial cells. 
Results represent the means ± SD of triplicates. Experiments were performed twice for 
Caco-2 cells (A) and 3 times for A549 cells (B), yielding similar results. The absolute 
values of the repeated experiments are in the range of 8 X 106 ± 1 X 106 CFU and 7 X 
106 ± 1 X 106 CFU for Caco-2 and A549 cells respectively. There is no statistically 
significant difference between wild-type and bsaQ mutant as analyzed by the student t-
test. 
 
2.3.2 Effect of B. pseudomallei infection on epithelial cell polarity and integrity 
The permeability of epithelial monolayer tight-junction barrier is assessed by the TEER, 
which is a measurement of the barrier to small ions in an experimentally applied 
electrical field in the bathing medium (Fanning et al., 1999). Hence, reduction in the 
TEER reflects an alteration of the epithelial cell barrier. To determine whether B. 
pseudomallei affects the barrier function of the apical-junctional complex, we measured 
changes in the TEER of Caco-2 cells upon exposure to bacteria. Only polarized, intact 
Caco-2 monolayer with a TEER of 330 Ω/cm2 was used. Apical infection of Caco-2 cells 
resulted in a decrease in TEER over time (Fig. 2.2.1A). This was not observed with 
uninfected cells. To assess the necessity of an intact bsa TTSS in mediating such an 
effect, a comparison was made between wild-type bacteria and the bsaQ mutant. The 
bsaQ mutant was able to reduce TEER to the same extent as the wild-type by 17 hours 
although there was a slight delay compared to wild-type bacteria (Fig. 2.2.1A). An 
avirulent strain, B. thailandensis also caused reduction in TEER but to a lesser extent 
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compared to wild-type bacteria (Fig. 2.2.1B). Several studies had demonstrated that 
bacterial pathogen-induced epithelial cell death occurred after 24 hours (Paesold et al., 
2002). However, using LDH assay, we were unable to detect lysis in Caco-2 cells after 17 
hours of infection (Fig. 2.2.1C). After 36 hours of infection, both wild-type and bsaQ 
bacteria did not induce death in Caco-2 and A549 cells above that of control uninfected 




Figure 2.2.1 Effect of B. pseudomallei infection on epithelial cell polarity and 
integrity. Time-dependent reduction in TEER induced by B. pseudomallei KHW, bsaQ 
mutant (A) and B. thailandensis (B) in Caco-2 cells with uninfected cells as control. 
Initial and TEER after infection were measured and reduction in TEER is expressed as 
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percentage change as compared to initial TEER reading. Results represent the means ± 
SD of 5 replicates. (C) Supernatants from the apical and basal compartments were 
measured for LDH levels after cells were infected with wild-type bacteria using 
Cytotoxicity Detection Kit with uninfected cells as controls. Results represent the means 
± SD of triplicates. All experiments were performed at three times with the similar 
results. 
 
Table 2.2.1 Effect of B. pseudomallei in induction of cell death in Caco-2 and A549 
epithelial cells. Cell death was assessed using TUNEL assay after 36 hours of infection. 
Results are expressed as fold increase in cell death relative to control uninfected cells. 
 
2.3.3 Time and dose dependent induction of IL-8 production in polarized Caco-2 
cells by B. pseudomallei 
Epithelial cells produce proinflammatory cytokines in response to bacterial infection, in 
particular IL-8 (Eckman et al., 1993; Jung et al., 1995; Pedron et al., 2003). We 
examined whether polarized Caco-2 cells secrete IL-8 in response to B. pseudomallei 
infection. Functionally intact Caco-2 cells were infected with B. pseudomallei apically 
and B. pseudomallei could elicit IL-8 secretion into the apical and to a lesser extent, the 
basal compartments (Fig. 2.3.1). This effect is time-dependent, where IL-8 secretion 
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reached a maximum at about 15 hours. It had been shown that IL-1 and TNF-α could 
directly lead to IL-8 production (Kasahara et al., 1991; Brasier et al., 1998). However, 
neither IL-1 nor TNF-α was produced (data not shown), indicating that B. pseudomallei is 
capable of provoking IL-8 secretion from epithelial cells without the help of TNF-α and 
IL-1. 
 
Figure 2.3.1 Time and dose dependent production of IL-8 induced by B. 
pseudomallei through apical infection of Caco-2 cells. Uninfected cells serve as 
control. The results represent the means ± SD for triplicate wells and are representative of 
two separate experiments.  
 
2.3.4 Bsa TTSS but not TLRs is involved in IL-8 induction from polarized Caco-2 
cells 
As flagellin is known to be a potent stimulus to the basolateral surface of polarized 
mucosal epithelial cells due to the expression of TLR5 (Gewirtz et al., 2001), we tested 
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the ability of KHW fliC mutant (Chua et al., 2003), which is aflagellate, to induce IL-8 
secretion in apical and basolateral infection. Apical and basal stimulation with fliC 
mutant could still induce IL-8 at comparable level as the wild-type (Fig. 2.4.1A and B). 
We were unable to induce significant amounts of IL-8 even with up to 5 μg/ml of purified 
B. pseudomallei recombinant flagellin cloned from KHW (Fig. 2.4.2A) or 2 μg/ml of E. 
coli LPS (Fig. 2.4.2C). The recombinant flagellin was not defective as it could stimulate 
NF-κB expression in HEK293T cells expressing TLR5 in a dose-dependent manner (Fig. 
2.4.2B). This raises the possibility that factors other than flagellin and LPS are involved 
in IL-8 induction. We further investigated if the bsa TTSS is functionally required to 
mediate the induction. As seen in Figures 2.4.1A and 2.4.1B, bsaQ mutant was less 
stimulatory than wild-type bacteria when applied apically and basolaterally.  
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 Figure 2.4.1 Comparison of IL-8 production induced by KHW, bsaQ and fliC 
mutants in Caco-2 cells. The cells were either apically (A) and basolaterally infected (B) 
at MOIs of 100:1 and 10:1 for 15 hours. Supernatant from apical and basal compartment 
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were assayed for IL-8 by ELISA.  Results represent the means ± SD for triplicate wells 




 Figure 2.4.2 IL-8 production from Caco-2 cells is independent of flagellin and LPS 
stimulation. The cells were stimulated either apically and basolaterally with flagellin (A) 
and LPS (C) for 15 hours before supernatant from apical and basal compartment were 
assayed for IL-8 by ELISA.  Results represent the means ± SD for triplicate wells and are 
representative of two separate experiments. (B) NF-κB activation was determined using 
HEK293T transfected with pTLR5 and pcDNA (control plasmid) after 7 hours of 
incubation with flagellin. NF-κB-directed luciferase expression is normalized to CMV-
directed constitutive luciferase expression and expressed as means ± SD. Results 
represent the means ± SD for triplicate wells and are representative of two separate 
experiments. 
 
2.3.5 B. pseudomallei induces low IL-8 compared to other bacteria 
As the level of IL-8 induced by B. pseudomallei was quite low, we compared the 
induction by other Gram-negative bacteria known to contact the mucosa. Both 
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Salmonella enterica serovar enteritidis and Salmonella enterica serovar typhimurium 
could induce much higher IL-8 levels than the Burkholderia species (Fig. 2.5.1).  
 
Figure 2.5.1 Comparison of IL-8 production induced by apical infection of B. 
pseudomallei and other bacterial species. The cells were infected at MOI of 100:1 for 
15 hours before the supernatant from apical and basal compartment were assayed for IL-8 
by ELISA. (Ctrl = unstimulated well, B.t = B. thailandensis, S.t = Salmonella enterica 
serovar typhimurium, S.e = Salmonella enterica serovar enteritidis). Results represent the 




Previous investigations on the interaction of B. pseudomallei with epithelial cells have 
involved the use of non-polarized epithelial cells. Unlike non-polarized epithelial cells, 
polarized epithelial is characterized by the presence of tight junctions, cell polarity and 
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functionally differentiated brush border microvilli (Kazmierczak et al., 2001; Berkes et 
al., 2003), hence are more representative of situation in vivo. In this study we investigated 
how B. pseudomallei interacts with the polarizable colon carcinoma cell line, Caco-2 and 
if the bsa TTSS in B. pseudomallei is involved in the process. Ideally, polarized lung 
epithelial cells would be a better model system than Caco-2 cells as the latter are 
intestinal cells and B. pseudomallei major route of entry is through nasal passages than 
through oral route. However, we experienced difficulty working with polarizable nasal or 
lung epithelial cell as these cells are difficult to grow even on normal tissue culture flask 
and we could not get the cells to be polarized. The nasal epithelium cells also secrete 
mucus, which was hard to handle. As Caco-2 cells have been well characterized, we used 
them as proof of principle to see if there are overt differences between polarized and non-
polarized epithelial cells.  In this study, only polarized Caco-2 monolayer with a TEER of 
330 Ω/cm2 is used. Previously, using confocal microscopy we have further confirmed that 
Caco-2 cells are polarized since transferrin receptors are expressed exclusively at the 
basolateral (Simons and Fuller, 1985; Gaillard and Finlay BB, 1996) but not the apical 
sites in polarized cells (data not shown). 
  It is well established that B. pseudomallei could invade and replicate in non-
polarized epithelial cells (Jones et al., 1996; Harley et al., 1998). Similarly, B. 
pseudomallei could invade and replicate in polarized epithelial cells as determined by the 
increased number of intracellular bacteria after 24-hour incubation. As bsaQ encodes a 
conserved structural component of the Type Three secretion apparatus, the mutant would 
be devoid of a functional bsa TTSS. Indeed, bsaQ mutant was shown to be defective in 
secreting effectors such as BopE and BipD into the supernatant as determined by Western 
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blot (Hii et al., 2008). However, bsaQ mutant was able to invade and replicate in Caco-2 
and A549 as effectively as wild-type contrasting Stevens et al. who had previously 
demonstrated that bopE and bipD mutants, with components of the bsa TTSS deleted, 
were less able to invade HeLa cells (Stevens et al., 2002). BopE was shown to induce 
actin cytoskeleton rearrangements and thus postulated to induce membrane ruffling and 
uptake. The discrepancy with our results could be due to the strain of B. pseudomallei we 
used as it was shown to be more invasive and no centrifugation of bacteria onto host cells 
is necessary for invasion, in contrast to what is reported (Stevens et al., 2003). The ability 
of B. pseudomallei to invade polarized epithelial cells indicates that B. pseudomallei can 
cross the epithelial barrier by the transcellular pathway to reach the underlying mucosal 
tissue. However, passage of many bacterial pathogens through the epithelial barrier is not 
restricted to a transcellular pathway as they are able to cross the epithelial barrier via the 
disruption of epithelial tight junctions (Wu et al., 1998; McNamara et al., 2001; Amieva 
et al., 2003). We found that apical infection could cause a reduction in TEER of Caco-2 
cells without a compromise in the viability of the cells. This reduction was not as great 
when the cells were infected with the non-pathogenic B. thailandensis, a closely related 
species to B. pseudomallei. This suggests that B. pseudomallei could invade via a 
paracellular route. However, detection in loss of tight junction proteins such as occludin 
or claudin following bacterial infection and transmigration of bacteria from apical to 
basal site would conclusively demonstrate this point. Indeed Burkholderia cepacia 
complex strains were demonstrated to alter expression of tight junction proteins allowing 
them to traverse the epithelial barrier (Kim et al., 2005c; Duff et al., 2006).    
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A feature of B. pseudomallei-induced pathology seen in animal models of 
infection (Barnes et al., 2001) as well as in patients (Wong et al., 1995) is the infiltration 
of polymorphonuclear cells to the mucosal sites. Epithelial cells could act as early sensors 
to bacterial invasion during mucosal infection through the production of chemokines and 
cytokines. Apical infection with B. pseudomallei resulted in IL-8 induction from the 
apical and to a lesser extent, the basolateral surface of the cells in a dose and time-
dependent manner. The increasing IL-8 production with time upon apical infection may 
be due to the reduction of TEER with time, resulting in a loss of epithelial polarity and 
tight junction integrity which contributes to the diffusion of IL-8 into the basal chamber. 
In our system, only transwell filters with pore size of 0.4 μm is used for cell seeding so it 
is not possible that the bacteria from the apical compartment have traversed across to 
activate receptors at the basolateral surface for IL-8 induction. However, basal 
stimulation of cells with B. pseudomallei also resulted in IL-8 secretion into the basal 
chamber with barely detectable levels in the apical site.  One of the major receptor 
systems for detection of pathogens in innate immunity is the TLRs (Akira, 2001). While 
others have shown that TLR5, a receptor that recognizes bacterial flagellin, is only 
expressed on the basolateral surface of polarized epithelial cells (Gewirtz et al., 2001), 
we were unable to detect significant amounts of IL-8 even with high and non-
physiological concentrations of recombinant B. pseudomallei flagellin protein upon basal 
and apical stimulation of Caco-2 cells. Furthermore, the fliC mutant which is equally 
invasive as wild-type (Chua et al., 2003) could induce comparable levels of IL-8 as wild-
type. Although low TLR5 expression could be particular to Caco-2 cells as compared to 
HT-29-19A cell line (Bambou et al., 2004), this does not affect our conclusion that IL-8 
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induction can occur in a TLR5 independent manner. The production of IL-8 was also 
independent of LPS. This is not surprising as epithelial cells have been shown to express 
low amounts of TLR4, the pattern recognition receptor for LPS as well as accessory 
molecules such as CD14 and MD2 (Abreu et al., 2001; Melmed et al., 2003). Thus, the 
induction of IL-8 in Caco-2 cells is largely independent of TLR4 and TLR5 stimulation. 
It is possible that B. pseudomallei could induce epithelial cell activation independent of 
TLRs, as we have shown that B. pseudomallei bsa TTSS was required to activate NF-κB 
which correlated with the pattern of IL-8 production in our reporter system (chapter 3), 
supporting our observation that bsaQ mutant induced much lower levels of IL-8 as 
compared to wild-type bacteria in Caco-2 cells. In contrast to Caco-2 cells, no difference 
in IL-8 production was noted between the two in A549 cells. Stimulation with flagellin 
and LPS on A549 yielded high IL-8 compared to control suggesting that stimulation via 
TLRs on A549 cells probably contribute to IL-8 induction. This observation is in line 
with Utaisincharoen et al. demonstrating that B. pseudomallei-induced IL-8 in A549 is 
not abolished by cytochalasin D treatment, possibly involvement of surface receptors 
(Utaisincharoen et al., 2004; Utaisincharoen et al., 2005). The bsaQ mutant is not 
impaired in its ability to invade and yet it exhibits low IL-8. One possibility is that bsa 
TTSS is required to secrete certain bacterial components across endosomal or vesicular 
membranes to contact intracellular receptors for recognition.  
Based on the results, it is possible that the ability of B. pseudomallei to enter non-
phagocytic polarized epithelial cells provides an important niche permissive for its 
replication and avoidance of host defense mechanisms. B. pseudomallei did not 
significantly cause epithelial cell death up to 36 hours of infection in contrast to 
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macrophages where cell death is induced within hours (Sun et al., 2005), allowing it to 
multiply to high numbers within epithelial cells. With time, B. pseudomallei could cause 
a reduction in TEER, allowing the bacteria to penetrate the mucosal epithelial cells to 
reach deeper tissues and interact with other immune cells such as the underlying tissue 
macrophages. The interaction of B. pseudomallei with other immune cells might also 
have an impact on epithelial cell barrier. Recent studies have shown that cytokines such 
as TNF-α and IFN-γ, both produced during B. pseudomallei infection, disrupt epithelial 
barrier function by altering the epithelial protein composition in the lateral membrane that 
is crucial for epithelial barrier function (Coyne et al., 2002; Bruewer et al., 2003). As IL-
8 is a potent chemoattractant for polymorphonuclear cells, it is likely to play an important 
role in inflammation. However, IL-8 induced by B. pseudomallei is much lower 
compared to Salmonella strains. One would argue that the contrasting IL-8 production by 
B. pseudomallei and Salmonella strains is a cell-type specific event as the latter and less 
so with Burkholderia is known to contact mucosal instestinal epithelial cells. Hence, it is 
important to investigate if this phenomenon is consistently observed across polarized 
epithelial cell lines or primary cells derived from lung and bronchia. The low induction of 
IL-8 is beneficial to B. pseudomallei infection as this could buy time for the bacteria to 
cross the epithelial layer into the underlying tissues before full-fledge inflammation 
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One of the disease manifestations of melioidosis is acute illness characterized by massive 
inflammation in susceptible individuals. Infection with B. pseudomallei can occur 
through inhalation and possibly ingestion and epithelial cells would be the first cells to 
encounter the microbes and are able to secrete a number of inflammatory cytokines once 
the epithelial integrity is disturbed (Hedges et al., 1995). The chemokine IL-8 plays a 
critical role in the initial defense against bacterial invasion as it can attract neutrophils to 
the invasion site to confront bacteria. Furthermore, neutrophils were recently shown to 
play a critical role in control of experimental melioidosis in mice (Easton et al., 2007). 
However, overproduction of IL-8 could also lead to massive infiltration of phagocytes 
associated with marked epithelial damage, dissemination of bacteria and production of 
uncontrolled inflammation resulting in severe septic shock (Perdomo et al., 1994; 
Sansonetti et al., 1999).  
During both septicemic and localized B. pseudomallei infection, IL-8 
concentration was found to be elevated in plasma of patients and mRNA was increased in 
leukocytes (Friedland et al., 1992). Serum IL-8 levels could be an indicator of poor 
prognosis in human melioidosis (Friedland et al., 1992), providing a compelling reason to 
elucidate the mode of induction of this important chemokine. B. pseudomallei-induced 
IL-8 production was previously described in the lung epithelial cell line, A549 
(Utaisincharoen et al., 2004; Utaisincharoen et al., 2005). Although NF-κB has been 
accepted as key in controlling IL-8 production, maximal induction is also aided by 
MAPK pathways either at the transcriptional level such as activation of AP-1 or at the 
post-transcriptional level such as in mRNA stabilization (Holtmann et al., 1999; 
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Hoffmann et al., 2002). Indeed, inhibition with the p38 inhibitor SB203580 could also 
decrease B. pseudomallei-induced IL-8 mRNA expression as well as IκB degradation 
(Utaisincharoen et al., 2005).  However, neither IL-8, IκB degradation nor p38 
phosphorylation were affected by treatment of cytochalasin D (Utaisincharoen et al., 
2004; Utaisincharoen et al., 2005), likely due to the involvement of surface PRR such as 
the TLR. One of the candidate receptors is TLR5, which recognizes bacterial flagellin 
and is only found at the basolateral surfaces of the epithelial cells (Gewirtz et al., 2001). 
In contrast to the study by Utaisincharoen et al., we found that B. pseudomallei bsa TTSS 
is required for IL-8 production in polarized Caco-2 cells likely independent of TLR 
stimulation as Caco-2 cells are poorly responsive to LPS and flagellin, the TLR4 and 
TLR5 ligands, respectively. The importance of TLR-independent IL-8 induction is 
particularly evident in cells where TLR is poorly expressed. Epithelial cells represent 
such cells and are poorly responsive to TLR agonists for several reasons. In addition to 
compartmentalization of TLR5 on the basolateral surface, epithelial cells express 
attenuated TLR2 and TLR4 and do not express coreceptor, CD14 which is required to 
transmit signal to TLR4. These render the cells refractory to stimulation by lipoprotein 
and LPS (Abreu et al., 2001; Melmed et al., 2003). These mechanisms presumably 
prevent the induction of a perpetual immune response against the bacterial components 
given that the epithelium is constantly bathed with resident bacterial flora. Despite the 
low TLR expression, epithelial cells are still able to initiate an inflammatory response 
after perturbation by pathogens, demonstrating the capability of epithelial cells to sense 
and respond to invasion.  In fact, evidence points to the intracellular PRR such as NOD1 
and NOD2 as major bacterial sensing receptors in epithelial cells (Travassos et al., 2005; 
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Zilbauer et al., 2007). Activation of NOD1 and NOD2 by derivatives of peptidoglycan 
initiates a variety of cellular responses including NF-κB and MAPK activation (Bertin et 
al., 1999; Girardin et al., 2001; Da Silva Correia et al., 2006).  Some pathogenic bacteria 
such as Yersinia co-opts the mammalian integrin receptor with invasin protein to activate 
a signaling cascade involving Rac1, MAP kinases, NF-κB, and subsequent production of 
chemokines (Schulte et al., 2000; Grassl et al., 2003).   
Recent reports have also underscored the importance of bacterial secretion system 
in signaling cascades leading to cytokine production. For example, H. pylori utilizes 
Type IV secretion system to deliver peptidoglycan into the cells to contact with NOD1. 
Similarly, the Type IV secretion system is also required for Legionella pneumophila to 
induce NF-κB activation but in a manner independent of TLR and NOD1 (Losick and 
Isberg, 2006).  Similarly, S. typhimurium can direct a TTSS effector, SopE into the host 
cell leading to nuclear responses (Hardt et al., 1998).   
In this study, using HEK293T cells which do not have any surface or endogenous 
TLR to simulate the condition in Caco-2 cells, we sought to dissect the mechanisms on 
how B. pseudomallei contribute to IL-8 production through its interaction with the NF-κB 








3.2 MATERIALS AND METHODS 
3.2.1 Bacterial strains 
All bacteria used in this study were as described in chapter 2 except E. coli, XL-1 blue 
(kind gift from Dr. Lu Jinhua, Dept of Microbiology, NUS), E. coli S17-1λpir containing 
plasmid pDM4-BopE (kind gift from Dr. Mark P. Stevens, Institute for Animal Health, 
UK) and another TTSS mutant, bsaU (bsaU::TnOT182) mutant which was identified by 
screening of a random transposon library of strain KHW, generated using methods 
described previously (Gan et al., 2002). To prepare heat-inactivated bacteria, overnight 
bacterial culture was subjected to heating at 100°C for 2 hours.  
 
3.2.2 Cell lines 
Human embryonic kidney HEK293T (ATCC CRL-11268) cells were cultured in DMEM 
medium (Sigma, St. Louis, MO) with 10 % heat-inactivated FBS (Biological Industries, 
Israel), 2 mM L-glutamine (Sigma), 100 U/ml penicillin and 0.1 mg/ml streptomycin 





Equal volume of overnight culture of B. pseudomallei was mixed with E. coli S17-1λpir 
containing plasmid pDM4-BopE. 50, 100 and 200 μl of mixed culture were added onto 
sterile cellulose nitrate filter disk (Diameter: 47 mm, pore size: 0.45 μm, Sartorius, 
Goettingen, Germany) overlying LB plates.  The plates were incubated at 37°C for either 
3 or 6 hours before the filters were transferred onto LB plates containing kanamycin (50 
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μg/ml) and chloramphenicol (50 μg/ml). Plates were incubated at 37°C for 24-28 hours, 
before single colony of bacteria were selected for further identification and verification.  
 
3.2.4 Bacterial growth curve  
 
To prepare mid-log phase bacteria, 10 ml LB medium was inoculated with 100 μl 
overnight culture and allowed to grow at 37°C with constant agitation. To determine if 
bopE mutants were defective in growth, 1 ml of bacteria culture was read at 600 nm 
every two hours until 8 hours with KHW as a positive control. 
 
3.2.5 Invasion assay 
To examine the effect of signaling inhibitors on bacterial invasion, cells were infected at 
MOI of 100:1 for 30 minutes, followed by antibiotic treatment for another 1 hour before 
lysis. Antibiotic treatment and extensive washing of the cells were necessary to minimize 
extracellularly bound bacteria. Plating was done as described in chapter 2. 
 
3.2.6 Western blotting 
For experiments analyzing phosphorylated MAPK, 4 x 106 cells infected with either 
wild-type or bsaQ mutant at MOI 100:1 were lysed at various time points after infection 
with cell lysis buffer (Cell Signaling Technology, Danvers, MA) containing 1 mM 
PMSF. Uninfected cells serve as negative controls. Cell debris was removed by 
centrifugation at 3000g for 5 minutes.  Twenty to fourty μg proteins were separated by 12 
% SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was probed 
with rabbit polyclonal antiserum to JNK, phospho-JNK (Thr183/Tyr185), p38, phospho-
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p38 (Thr180/Tyr182), or ERK, phospho-ERK (Thr202/Tyr204) according to 
manufacturer’s instructions (Cell Signaling Technology, Danvers, MA). Densitometric 
analysis of protein bands on the film was performed with Image J. 
To verify bopE mutants, 5 mL log phase culture of bopE mutants (#9, #11, #12, 
#13) with wild-type and bsaQ mutant as positive controls were centrifuged at 3000g for 5 
minutes. Bacterial pellet was lysed with bacterial lysis buffer (8M Urea, 0.1M NaH2PO4, 
0.01M Tris-HCI, pH8). 25 μg of protein from bacteria lysate was separated by 12 % 
SDS-PAGE and transferred to nitrocellulose membrane. The membrane was probed with 
rabbit polyclonal antiserum to BopE or BipD (kind gift from Dr. Mark P. Stevens, 
Institude for Animal Health, UK) at 1:100 dilution overnight and detected with 
horseradish peroxidase-conjugated mouse anti-rabbit IgG (1:2000, Cell signaling, 
Danvers, MA).  The membrane was washed 3 times and immersed in Enhanced 
chemiluminescence (ECL) detection reagent (Amersham) for detection of bound HRP-
conjugated secondary antibody by chemiluminesence.  
 
2.3.7 Analysis of transfection efficiency in HEK293T by fluorescence microscopy 
Cells were seeded on the cover slips inside the wells at density of 2.5 x 105 overnight 
before the cells were transfected with various concentrations (0.5 - 2.0 μg) of plasmid 
expressing GFP, pEGFP-NI (Clontech) for 24 hours. The cells were washed twice with 
1x PBS before they were fixed with iced-cold methanol at -20°C for 10-30 minutes. The 
cells were washed twice with 1x PBS before the cover slips were mounted onto the 
microscope slides with Dako fluorescent mounting media (Dako Corporation, 
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Carpinteria, CA, USA).  Fluorescent images were obtained with Leica DMLB 
microscope at magnification of 100X.  
 
3.2.8 siRNA transfection and gene knockdown analysis  
Cells were seeded at 2.5 x 105 cells per well 24 hours before the cells were transfected 
with 50 nM and 75 nM of either NOD1 siRNA (F: 5’-
ACAACUUGCUGAAGAAUGACU-3 and R: 5’-AGUCAUUCUUCAGCAAGUUGU-
3’) or random nucleotide (negative control) sequence (F: 5’-
UUCUCCGAACGUGUCACGUTT-3’ and R: 5’-ACGUGACACGUUCGGAGAATT-
3’) using Gene Silencer (Gelantis, San Diego, CA) with varying amounts of lipid  (either 
0.75 or 1.00 μl per 100 ng of siRNA).  This condition was established by using 
fluorescein-tagged siRNA to determine the optimal lipid concentration used for 
transfection. 48 hours after transfection, RNA was isolated using Trizol (Invitrogen, 
Carlsbad, CA) before 2 μg of RNA was subjected to reverse transcription using High 
Capacity cDNA Reverse Transcriptase kit (Applied Biosystems, Foster City, CA). Real-
time PCR was performed with iQ5 real-time PCR detection system (BioRad, Hercules, 
CA) using 100 ng of cDNA template for each sample mixed with target gene (NOD1 or 
NOD2) or endogeneous gene, GADPH-specific primers and SYBR Green ERTM qPCR 
reagent (Invitrogen, Carlsbad, CA). The cycling parameters for amplification gene 
specific primers were as follows: 50°C for 2 min, 95°C for 8 min and 30s followed by 42 
cycles at 95°C for 15s and 60°C for 1 min. PCR cycling for each cDNA sample was 
performed in triplicates. To examine the effect of MAPK inhibitors on induction of IL-8 
mRNA, cells were either treated for 1 hour before the cells were infected with either 
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KHW or bsaQ mutant at MOI of 100:1 for 4 hours. RNA was isolated and an increase in 
IL-8 mRNA was determined using real-time PCR.  Genes specific primers used were 
NOD1-F (5’-CAGAGCAAAGTCGTGGTCAA-3’), NOD1-R (5’-
ACAGCACGAACTTGGAGTCA-3’), NOD2-F (5’-GAATGTGCTCTTCACTGCGA-
3’), NOD2-R (5’-CAAGGAGCTTAGCCATGGAG-3’), IL-8-R (5’-
CCTTGGCAAAACTGCACCTT-3’), IL-8-F (5’-CTGGCCGTGGCTCTCTTG-3’), 
GADPH-F (5’-ATGGAAATCCCATCACCATCRR-3’) and GADPH-R (5’-
CGCCCCACTTGATTTTGG-3’). 
 
3.2.9 Transmission Electron Microscopy (TEM) of infected cells 
4 × 106 cells infected with bacteria at MOI of 100:1 were harvested 2 hours after 
infection. Samples were fixed in 2.5 % glutaraldehyde in PBS buffer overnight at 4oC, 
then postfixed with 1 % osmium tetraoxide in PBS for 2 hours at 4oC. Samples were 
dehydrated sequentially through 30, 50, 70, 90, and 100 % ethanol, and finally in 
propylene oxide prior to infiltration with Spurr resin. Samples were embedded in 100 % 
resin and polymerized at 60oC for 24 hours. Ultra-thin sections were cut on a Jung 
Reichert ultra-microtome and examined with a transmission electron microscope 
(JEM1010, JEOL, Japan) at 100 KV. 
 
3.2.10 Detection of IL-8 by ELISA 
IL-8 production was examined in cells stimulated with flagellin for 7 hours or infected 
with bacteria at MOI of 100:1 for 15 hours before the supernatant were collected and 
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assayed for IL-8 by ELISA (Bender MedSystems, Vienna, Austria).  For infected cells, 
40 μg/ml of tetracycline was added two hours after infection.  
 
3.2.11 Detection of NF-κB activation 
NF-κB activation was measured as previously described in chapter 2.  Briefly, after 
HEK293T cells transfected with two luciferase reporter plasmids using the 
GenePORTER 2 reagent (Gene Therapy System, La Jolla, CA) overnight, the cells were 
infected with wild-type or mutant at MOIs of 100:1 and 10:1 in antibiotic-free medium. 
After 2 hours, fresh medium containing 40 μg/ml of tetracycline were added and cells 
were further cultured for 5 hours. The cells were lysed and luciferase expression was 
determined in chapter 2. The cells were also co-transfected with human TLR2, TLR4, 
TLR5, MD2, CD14 (Zhang et al., 2002) and stimulated with Pam3Csk4 (Invivogen), 
ultrapure LPS (Invivogen) or flagellin for 7 hours before NF-κB activation was assayed. 
Pam3Csk4 is a synthetic tripalmitoylated lipopeptide that mimics the acylated amino 
terminus of bacterial lipoprotein that signals through TLR2. To produce B. pseudomallei 
recombinant flagellin, the flagellin gene with a 6x-Histidine tag at the N-terminus was 
first cloned into the expression vector pQE-30 (Qiagen, Germany) and transformed into 
E. coli M15 cells, and then expressed and purified as previously described in chapter 2. 
The same infection and transfection procedures were adopted for both inhibitors and 
dominant negative (dn) studies. IκB super-repressor plasmid was a kind gift from Dr. 
Baldwin A, University of North Carolina, Chapel Hill. Dn MyD88 was generated from 
human macrophages as previously described (Zhang et al., 2002).  Varying inhibitor 
concentrations of MG132, U0126, PD98059, SB203580, SP600125, wortmannin and 
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LY294002 diluted in DMSO were added to cells for 1 hour at 37oC before infection. All 
inhibitors are from Calbiochem (San Diego, CA) except MG132 and wortmannin 
(Sigma). 
 
3.2.12 Statistical analysis 
All results were analysed pairwise by the student t-test. A p-value of less than 0.01 was 
considered significant. Asterisk* represents a statistically significant difference between 
inhibitor-treated versus DMSO-treated cells. 
 
3.3 RESULTS 
3.3.1 TTSS dependent NF-κB activation by B. pseudomallei 
Our previous results indicated that B. pseudomallei could induce Caco-2 cells to secrete 
IL-8 in a TLR-independent manner which requires the bsa TTSS. To dissect this TTSS-
dependent yet TLR-independent mechanism of activation, we used HEK293T cell line as 
these cells have little or no surface expression as well as endogenous TLRs (Hornung et 
al., 2002). We confirmed that HEK293T cell line did not respond to any TLR agonists 
except weakly to flagellin, the TLR5 agonist unless cells were transfected with their 
respective TLR plasmids (Fig. 3.1.1). Thus, if B. pseudomallei could trigger NF-κB 
activation, this would occur in a TLR-independent manner. We found that infection with 
B. pseudomallei could activate NF-κB in a dose dependent manner, whereas minimal NF-
κB activation was observed with the bsaQ mutant (Fig. 3.1.2A). bsaU, another TTSS 
mutant also showed defective NF-κB stimulation with a 3 fold reduction compared to 
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wild-type bacteria (Fig. 3.1.2B), indicating that the bsa TTSS is functionally required to 
mediate NF-κB activation. 
 
Figure 3.1.1 HEK293T cell line expresses little surface TLR. Comparison of NF-кB 
activation induced by TLR agonists in pcDNA- and TLRs-transfected HEK293T cells 
after stimulation for 7 hours with 1 μg/ml of TLR2 agonist (Pam3Csk4), TLR4 agonist 
(ultrapure LPS) and TLR5 agonist (flagellin). NS denotes the non-stimulated cells. NF-
κB activation was determined as described in Material and Methods. NF-κB-directed 
luciferase expression is normalized to CMV-directed constitutive luciferase expression. 
Experiments were performed twice and results represent the means ± SD of triplicates. 
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 Figure 3.1.2 B. pseudomallei bsa TTSS is necessary for NF-кB activation in 
HEK293T cells.  Dose-dependent NF-κB activation using HEK293T cells transfected 
with reporter plasmids induced by KHW and bsaQ mutant (A) or with bsaU mutant (B).  
All results represent the means ± SD from triplicates. Experiments were repeated three 
times for (A) and two times for (B).  Error bars in (B) were too small to be seen. 
 
3.3.2 Internalization is required for B. pseudomallei-induced NF-κB activation and 
IL-8 secretion 
We next determined if internalization of bacteria is required for activation or other cell 
surface receptors are involved. We show that invasive B. pseudomallei activated higher 
level of NF-κB compared to less invasive strains such as B. thailandensis and E. coli 
(Fig. 3.2.1). The ability of the bacteria to activate NF-κB was abolished once the bacteria 
were heat-inactivated (Fig. 3.2.1).  To provide direct evidence on the requirement for 
internalization, we used cells pretreated with cytochalasin D prior to infection with 
bacteria. Cytochalasin D is known to inhibit actin polymerization and thus, inhibit 
bacterial invasion into mammalian cells. Treatment of cytochalasin D abrogated the 
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ability of wild-type and to lesser extent the bsaQ mutant to activate NF-κB (Fig. 3.2.2A). 
NF-κB activation correlated with the IL-8 induction (Fig. 3.2.2B). Treatment with 
cytochalasin D also diminished IL-8 secretion in cells infected with both wild-type 
bacteria and bsaQ mutant likely through reducing bacterial internalization (Fig. 3.8.2). 
The reduced stimulatory activity of bsaU mutant was also reflected in low IL-8 induction 
(Fig. 3.2.2C) that correlated to the low NF-κB activation (Fig. 3.1.2B). To exclude any 
non-specific effects of cytochalasin D on IL-8 secretion, we assessed NF-κB and IL-8 
induction through flagellin stimulation of TLR5. HEK293T cells transfected with TLR5 
and stimulated with flagellin were able to activate NF-κB (Fig. 3.2.3A) and produced IL-
8 in the presence of cytochalasin D (Fig. 3.2.3B) as would be expected because flagellin 
could activate TLR5 without requiring internalization.  
 
Figure 3.2.1 Live but not heat-inactivated bacteria induce NF-кB activation in 
HEK293T cells. Comparison of live and heat-inactivated B. pseudomallei (KHW), B. 
thailandensis and E. coli (XL-1blue) in their ability to trigger NF-κB activation in 
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HEK293T cells transfected with reporter plasmids. Heat-inactivated bacteria were 
obtained by heating the bacterial culture at 100°C for 2 hours. Results represent the 
means ± SD from triplicates and are representative of two separate experiments. 
 
Figure 3.2.2 B. pseudomallei entry is necessary for NF-кB activation and IL-8 
production. Comparison of NF-кB activation (A) and IL-8 production (B) in 
cytochalasin D (Cyt D) treated- and non-treated HEK293T cells induced by KHW and 
bsaQ mutant at MOI of 100:1. The cells were pretreated with 2 μg/ml of cytochalasin D 
for 1 hour before infection was performed. NF-кB activation and IL-8 ELISA were 
assayed after 7 and 15 hours of infection, respectively. (C) IL-8 production induced by 
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KHW and bsaU mutant. All results represent the means ± SD from triplicates. 
Experiments were repeated three times for (A) and (B) and two times for (C).   
  
Figure 3.2.3 Cytochalasin D does not affect flagellin-induced NF-κB activation and 
IL-8 induction. HEK293T cells transfected with TLR5 and pcDNA (plasmid control) 
was stimulated with 1 μg/ml of flagellin (FliC) for 15 hours before NF-кB (A) activation 
and IL-8 (B) production were assayed. All results represent the means ± SD from 











3.3.3 Invasion and intracellular localization of B. pseudomallei and bsaQ mutant 
We next examined whether the reduced ability of bsaQ to induce IL-8 and NF-κB 
activation is due to its poor capacity to invade or replicate intracellularly. Similar 
numbers of bacteria were found at 4 and 24 hours (Fig. 3.3.1A), indicating that bsaQ 
could invade and replicate as well as wild-type bacteria in epithelial cells.  To ensure that 
bsaQ mutant does not have a defect in adherence thus contributing to lower cellular 
activation, experiments were performed with or without centrifuging the bacteria onto 
cells. As expected, there was no difference in results for both wild-type and mutant 
bacteria in NF-κB activation and IL-8 production (Fig. 3.3.1B) whether they were 
centrifuged or not. This agrees with the internalization data where no difference was 
observed between the wild-type and mutant. Hence, all the subsequent infection 
experiments were performed without centrifugation. 
Previously, it was reported that bsaZ and bipD mutants are unable to escape from 
endocytic vesicles within host cells (Stevens et al., 2002).  When we examined the 
cellular localization of B. pseudomallei by transmission electron microscopy (TEM), we 
counted equal numbers of wild-type bacteria (average of 30) in the cytosol (Fig. 3.3.1C) 
or in vesicles with intact membranes from 40 cells (Fig. 3.3.1D).  Similar results were 










 Figure 3.3.1 Binding, invasion, intracellular replication and localization of B. 
pseudomallei and bsaQ mutant in HEK293T cells. (A) Invasion experiments were 
performed twice, yielding similar results. Results represent the means ± SD of triplicates. 
No significant difference was observed between intracellular KHW and bsaQ as 
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determined by t-test. (B) NF-κB activation and IL-8 production were determined in cells 
infected with bacteria at MOI of 100:1 without or with centrifugation at 150g for 5 
minutes. Experiments were performed twice and results represent the means ± SD of 
triplicates. Transmission electron micrographs showing intracellular localization of B. 
pseudomallei KHW (C-D) and bsaQ mutant (E-H) in HEK293T cells at 2 h after 
infection. At least 40 cells infected with each strain were examined for intracellular 
location of bacteria (indicated by arrow) and representative images are shown.  There is 
no statistically significant difference in number of bacteria in cytosol or vesicles between 
KHW and bsaQ.  
 
3.3.4 NF-κB activation is independent of TLR pathways  
TLRs are known to recruit MyD88 adaptor to transduce signals (Janssens et al., 2002; 
Takeuchi and Akira, 2002). Figure 3.4.1 shows that cells transfected with dn MyD88 had 
no effect on NF-κB activation after bacterial stimulation. On the contrary, the same 
amount of dn MyD88 plasmid transfected in cells overexpressing TLR2, TLR4, TLR5, 
pcDNA/IL-1 abrogated NF-κB activation in response to their agonists (Fig. 3.4.2). As 
neither IL-1 nor TNF-α was produced in HEK293T cells (data not shown), B. 
pseudomallei-mediated signal transduction is unlikely to be attributed to the secondary 
effect of these cytokines.  
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 Figure 3.4.1 Dn MyD88 does not affect B. pseudomallei-induced NF-κB activation. 
Cells transfected with dn MyD88 were infected for 7 hours with B. pseudomallei at MOI 
of 100:1. pcDNA represents cells transfected only with the pcDNA plasmid and are used 
as a negative control. Control represents cells that were not infected with bacteria. 
Experiments were performed twice and results represent the means ± SD of triplicates.  
 
Figure 3.4.2 Dn MyD88 abrogates NF-кB activation in response to TLR agonists 
and IL-1.  HEK293T cells transfected with TLR2, TLR4/MD2/CD14, TLR5 and pcDNA 
were stimulated with their respective agonists at 1 μg/ml or IL-1 at 20ng/ml for 7 hours 
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before NF-кB assay was performed. Experiments were performed twice and results 
represent the means ± SD of triplicates. 
 
3.3.5 Generation, characterization and functional role of bopE mutants in NF-κB 
and IL-8 induction. 
Previously, Stevens et al. showed that a TTSS effector bopE serves as activator by 
exhibiting guanine nucleotide exchange factor activity for Rac1 and Cdc42 (Steven et al., 
2003). Given that Rac1 and Cdc42 play a role in NF-кB pathway, it seems reasonable to 
envisage that BopE could be a potential TTSS effector in activating NF-κB.  We created 
the bopE mutant by performing conjugation using wild-type B. pseudomallei and E. coli 
S17-1λpir containing plasmid pDM4-BopE (Steven et al., 2003).  Whole cell extracts 
from all bopE mutants were screened by Western blot using rabbit polyclonal antiserum 
to BopE. Out of the 16 bopE mutants, only four (#9, #11, #12, and #13) exhibited barely 
noticeable BopE protein after knockout, while BopE protein was still detectable with 
wild-type and bsaQ mutant lysate (Fig. 3.5.1A). The same membrane was stripped and 
reprobed with rabbit polyclonal antiserum to BipD, another TTSS translocon protein. As 
expected, the four bopE mutants still exhibited same level of BipD protein as the wild-
type and bsaQ mutant. These 4 mutants were picked for further analysis. Next, the 
growth rate of the bopE mutants was compared with the wild-type. As indicated in Figure 
3.5.1B, the four bopE mutants grew at a similar rate as the wild-type. We further assessed 
whether bopE mutants were impaired in invasion since Steven et al. had indicated the 
requirement of bopE in facilitating bacterial entry. The bopE mutants were able to invade 
HEK293T as demonstrated by similar amount of bacteria found intracellularly in cells 
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infected with bopE mutants and wild-type (Fig. 3.5.1C). This observation further 
reinforces our previous results showing BopE was not required for bacterial entry at least 
with our bacterial strain. We further tested if bopE mutant exhibit reduced ability to 
trigger NF-κB and IL-8 production. As shown in Figures 3.5.2A and B, the bopE mutants 




Figure 3.5.1 Generation and characterization of bopE mutants. (A) Western blot 
analysis of BopE and BipD expression from lysate of KHW, bsaQ and bopE mutants (#9, 
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#11, #12, #13). Approximately 25 µg of total protein was probed with rabbit polyclonal 
antiserum to BopE and BipD and detected with an anti-rabbit alkaline phosphatase 
conjugate. The sizes of the proteins are shown on the left. (B) Comparison of growth rate 
in LB medium (B) and invasion and intracellular replication (C) of KHW and bopE 
mutants in HEK293Tcells after 4 hours of infection. Experiments were performed twice 
and results represent the means ± SD of triplicates. 
 
Figure 3.5.2 BopE is not the effector for NF-κB activation and IL-8 production. 
HEK293T cells transfected with luciferase reporter plasmids were infected with bopE, 
 
bsaQ mutants and KHW at MOI of 100:1 before assayed for NF-κB activation (A) and 
IL-8 production (B). Experiments were performed three times and results represent the 
means ± SD of triplicates. 
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3.3.6 NF-κB activation is required for IL-8 induction 
To directly determine the contribution of NF-κB to IL-8 production, we employed IκB 
per-repressor (SR) to inhibit NF-κB activation. IκB SR contains IκBalpha sequence 
lation resistant A32/A36. Cells 
su
which is mutated at ser32/ser36 to form a phosphory
transfected with IκB SR at concentration of 250 ng per well did not significantly affect 
IL-8 levels although it successfully shut down NF-κB activation (data not shown). One of 
the explanations as to why the IL-8 production did not correlate with reduced NF-κB 
activation could be that for IL-8, most of the cells might not be transfected, so they would 
still produce IL-8 upon infection and while for NF-κB, NF-κB was measurable only from 
the minority of cells transfected and was not affected by the untransfected cells. To 
investigate this possibility, we examined the transfection efficiency in HEK293T cells 
with different concentrations of plasmid expressing GFP by fluorescence microscopy. 
Two individual slides containing transfected cells were analysed and only cells 
expressing green fluorescence were considered transfected. At 0.5 μg of plamids, only 50 
- 60 % cells expressed GFP (Fig. 3.6.1A) in comparison to ~ 70 % (Fig. 3.6.1B) or ~ 85 
% (Fig. 3.6.1C) of cells expressing GFP when they were transfected with 1.0 μg and 1.5 
μg of plasmids, respectively. At higher concentration of 1.8 μg, almost all the cells 
expressed GFP (~ 98 %) (Fig. 3.6.1D). Hence, we repeated the experiments with higher 
concentrations of IκB SR plasmids. NF-κB activation was drastically suppressed (Fig. 
3.6.2A) at concentrations of 0.5 – 1.8 μg of plasmid although only a 20-30 % decrease in 
IL-8 production was observed (Fig. 3.6.2B). We also used MG132, a proteasome 
inhibitor known to block NF-κB activation. At various MG132 concentrations of 10 - 50 
μM, a 25 - 40 % reduction in IL-8 production (Fig. 3.6.3B) was observed although NF-
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κB reduction was not as drastic (Fig. 3.6.3A) as with the IκB SR plasmids. However, our 
data with the IκB SR showed that although NF-κB is required for IL-8 induction, its role 
is only partial. 
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Figure 3.6.1 Transfection efficiency in HEK293T cells. The cells were transfected with 
different concentrations of plasmid expressing GFP; 0.5 μg (A), 1.0 μg (B), 1.5 μg (C) 
and 1.8 μg (D) for 24 hours before the cells were examined with a fluorescence 
microscope.  Left panel represents photographs of transfected cells expressing GFP and 
their corresponding micrographs of cells on the right panel. Experiments were peformed 
twice and representative images were shown.  
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 Figure 3.6.2 Effect of different concentrations of IκB SR plasmids on NF-κB 
activation and IL-8 production. The cells were transfected with (0.5-1.8 μg) of IκB SR 
plasmid or with pcDNA as a negative control overnight. The cells were infected with 
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KHW at MOI of 100:1 before assayed for NF-κB activation (A) and IL-8 production (B). 
Experiments were repeated twice and results represent the means ± SD of triplicates. 
 
 
Figure 3.6.3 Effect of different concentrations of MG132 on NF-κB activation and 
IL-8 production. The cells were treated with (10-50 μM) of MG132 one hour prior to 
infection with KHW at MOI of 100:1 before being assayed for NF-κB activation (A) and 
IL-8 production (B). Experiments were repeated twice and results represent the means ± 
SD of triplicates. 
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3.3.7 Effect of NOD1 siRNA on B. pseudomallei-induced NF-κB activation and IL-8 
production. 
In our system, a complete blockade of NF-κB activation and IL-8 production by bacterial 
internalization could mean the involvement of leucine rich repeat (LRR)-containing 
intracellular PRR such as NOD1 or NOD2. In HEK293T cells, NOD2 mRNA was 
weakly expressed and upon infection NOD2 was downregulated compared to NOD1 
(data not shown), eliminating NOD2 as a potential receptor.  We then investigated the 
involvement of NOD1 on NF-κB and IL-8 production using siRNA knockdown. Cells 
were also transfected with random nucleotide (RN) which serves as a negative control. 
Forty-eight hours after transfection, only cells transfected with NOD1 siRNA but not 
with RN exhibited about 70 % knockdown in NOD1 (Fig. 3.7.1A). Another NOD1 
siRNA (F: 5’-AAGAGCCUCUUUGUCUUCACC-3’ and R: 5’- 
GGUGAAGACAAAGAGGCUCUU-3’) was not able to result in any knockdown in 
NOD1 (data not shown). The knockdown is specific as both did not have any effect on 
NOD2.  Neither NF-κB nor IL-8 was affected by NOD1 knockdown (Fig. 3.7.1B), 
indicating that NOD1 was not activated by B. pseudomallei.  
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 Figure 3.7.1 Effect of NOD1 siRNA on B. pseudomallei-induced NF-κB and IL-8 
production in HEK293T cells.  Cells transfected with 50 nM and 75 nM of NOD1 
siRNA and random nucleotide (RN) using varying concentrations of transfection lipid 
(0.75 μl or 1.00 μl per 100 ng of siRNA) for 48 hours before NOD1 knockdown 
efficiency was determined by real time PCR (A). The cells cotransfected with siRNA and 
NF-κB reporter plasmid were tested for NF-κB activation (B) or IL-8 (C) by ELISA after 
15 hour of infection with B. pseudomallei at MOI of 100:1. Control (Ctrl) represents 
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uninfected cells. Experiments were performed two times and results represent the means 
± SD of triplicates. 
 
3.3.8 NF-κB activation is mediated through PI3 and MAP kinase pathways. 
IL-8 induction had been reported to be dependent on phosphoinositide-3-kinase (PI3K) 
and MAPK pathways (Holtmann et al., 1999; Hoffmann et al., 2002; Welch et al., 2003). 
To assess if PI3K and MAPK are involved, cells were pretreated with the inhibitors for 
one hour before bacterial infection. PI3K inhibitors, wortmannin and LY294002, reduced 
NF-κB (Fig. 3.8.1A) and IL-8 (Fig. 3.8.1B) levels. MAPK p38 inhibitor, SB203580 is the 
most potent inhibitor by completely blocking NF-κB activation at 10 μM (Fig. 3.8.1A). 
Specific inhibitor for c-Jun N-terminal kinase (JNK), SP600125 only partially prevented 
bacterial induced-NF-κB activation at 10 μM although maximal inhibition of up to 50 % 
was observed at a 30 μM. Reduction in nuclear response correlated with IL-8 induction 
with both p38 and JNK inhibitors (Fig. 3.8.1B). MEK1/2 and extracellular regulated 
kinase (ERK1/2) inhibitors (UO126 and PD98050, respectively) weakly reduced nuclear 
response even at a high concentrations although IL-8 inhibition was still observed (Fig. 
3.8.1.A and B). This is in agreement with our data that NF-κB did not solely control IL-8 
production. As PI3K and MAPK pathways have been demonstrated to play a role in 
bacterial internalization (Tang et al., 1998; Allen et al., 2005; Kierbel et al., 2005; Hu et 
al., 2006), we examined the effects of the inhibitors on bacterial entry.  We found that 
PI3K, p38 and JNK but not ERK inhibitors reduced bacterial entry significantly (Fig. 
3.8.2).  Thus, the ability of these inhibitors to inhibit NF-κB and IL-8 production could be 




 Figure 3.8.1 Effect of PI3K and MAPK inhibitors on B. pseudomallei-induced NF-
κB activation (A) and IL-8 production (B) in HEK293T cells. HEK293T cells were 
pretreated with various inhibitors at indicated concentrations for 1 hour prior to infection. 
Cells treated with DMSO only serves as negative controls.  NS represents not 
stimulated/infected with bacteria. Experiments were performed three times and results 
represent the means ± SD of triplicates. 
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 Figure 3.8.2 Effect of PI3K and MAPK inhibitors on B. pseudomallei invasion in 
HEK293T cells. Cells were treated with PI3K (A) and MAPK (B) inhibitors with DMSO 
(negative control) one hour prior to B. pseudomallei infection at MOI of 100:1. After half 
an hour, 40 μg/ml tetracycline was added and further incubated for another hour. The 
cells were thoroughly washed three times with PBS, followed by cell lysis and plating. 
Experiments were performed three times and results represent the means ± SD of 
triplicates. 
 
3.3.9 MAPK control IL-8 at the transcriptional level 
It is known that modulation of transcription of IL-8 is governed by JNK and ERK MAPK 
pathway while p38 MAPK has been implicated in stabilization of the mRNA (Holtmann 
et al., 1999; Hoffmann et al., 2002). We had observed that all MAPK participated in IL-8 
production. To see if these MAPK are affecting IL-8 at transcriptional or post-
transcriptional level, we investigated induction of IL-8 mRNA from MAPK inhibitors 
pretreated-cells following 4 hours infection with the bacteria.  All the MAPK inhibitors 
including U0126 at 20 μM and PD98059 at 30 μM effectively suppressed the level of IL-
8 mRNA (Fig. 3.9.1) which corresponded well with previous data on IL-8 production by 
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ELISA. We also found that with time, KHW upregulated IL-8 mRNA to a greater extent 
with minimum increase observed with bsaQ mutant (Fig. 3.9.2).  No differences in 
mRNA stability were seen between the two (data not shown), hence MAPK could act at 
transcriptional level contributing to differential IL-8 observed between the wild-type and 
bsaQ mutant. 
 
Figure 3.9.1 Effect of MAPK inhibitors in induction of IL-8 mRNA. HEK293T cells 
were treated with SB203580 (10 μM), SP600125 (30 μM), U0126 (20 μM) and PD98059 
(30 μM) MAPK inhibitors one hour prior to infection with KHW at MOI of 100:1 for 4 
hours. Fold increase in IL-8 in infected cells was determined by real time PCR and 
compared to non-infected cells. Experiments were performed two times and results 
represent the means of triplicates. 
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 Figure 3.9.2 Comparison of KHW and bsaQ mutant in transcription of IL-8 mRNA. 
The cells were infected at MOI of 100:1 and at various time points after infection, IL-8 
mRNA was determined by real time PCR. Experiments were performed two times and 
results represent the means of triplicates. 
 
3.3.10 MAPK activation in HEK293T cells infected with B. pseudomallei and bsaQ 
mutant 
IL-8 induction was greatly influenced by p38 and JNK inhibitors and to a lesser extent 
with ERK inhibitors. To gain further insights into which MAPK is specifically activated 
by bsa TTSS and hence contributes to IL-8 induction, we compared MAPK activation in 
HEK293T cells following infection with KHW and bsaQ mutant. Active MAPK are 
phosphorylated at the conserved Ser/Thr residues and are detected using antibodies 
against phospho-MAPK. The same blot was stripped and reprobed with antibodies for 
total MAPK. To eliminate the possibility that differential MAPK activation was due to 
uneven loading, densitometry analysis was performed. Unstimulated HEK293T cells 
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expressed constitutive MAPK.  Upon infection, only JNK and ERK were differentially 
activated by B. pseudomallei bsa TTSS. Whereas JNK activation was upregulated by 
wild-type bacteria with activation up to 2 fold higher activation achieved at 120 minutes 
(Fig. 3.10.1A), ERK activation was downregulated at 90 minutes after infection (Fig. 
3.10.1B). Both bsaQ mutant and KHW activated p38 but no significance difference was 
observed between the two (Fig. 3.10.1C). Although p38 and JNK MAPK were involved 
in bacterial internalization, the late induction at 120 minutes would not have contributed 
to a difference in bacterial entry, which agrees with our data showing no difference 
between wild-type and bsaQ mutant in internalization. The difference in JNK activation 
at 120 minutes likely contributes to the difference in IL-8 production between wild-type 
and bsaQ mutant. Since IL-8 production was only greatly affected using 10 μM of JNK 
but not ERK inhibitors, the contribution of ERK to IL-8 transcription could be minimal 







Figure 3.10.1 MAPK activation in HEK293T infected with KHW and bsaQ mutant. 
Cells were infected at MOI of 100:1 with no antibiotics added and lysed at various times 
(in minutes). The membrane was blotted with antibodies against phosphorylated (upper 
panel) or total (lower panel) of JNK (A), ERK (B) and p38 (C). The graphs depict 
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relative MAPK activation which refers to the ratio of the band density of phosphorylated 
over total protein for each sample and were presented as a relative value to that of control 
(ctrl) cells.  Phospho-JNK and ERK contains 2 bands of (p46, p54) and (p42, p44), 
respectively while phospho-p38 contain one band of p38.  Results are representative of 
two separate experiments. 
 
3.3.11 Comparison of B. pseudomallei and Salmonella strains in NF-κB activation 
and IL-8 production 
To see if the ability of MAPK and PI3K to inhibit NF-κB activation and IL-8 production 
is specific to the intracellular property of B. pseudomallei, we compared the ability of 
other intracellular pathogens such as Salmonella in such events.  Salmonella serovar 
Enteritidis and Typhimurium were equally stimulating as B. pseudomallei in NF-κB 
activation (Fig. 3.11.1A) but the IL-8 induction was much lower compared to B. 
pseudomallei (Fig. 3.11.1B). Only PI3K (Ly94002) and p38 MAPK (SB203580) 
inhibitors partially blocked Salmonella-induced NF-κB and IL-8 induction. Unlike B. 
pseudomallei, internalization is not required as cytochalasin D treatment did not affect 
both events (Fig. 3.11.2A and B).  
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 Figure 3.11.1 Comparison of B. pseudomallei and Salmonella strains in NF-κB 
activation and IL-8 production. Cells transfected with reporter plasmids were infected 
with bacteria at MOI of 100:1 before they were assayed for NF-κB activation (A) and IL-
8 production (B). Experiments were performed two times and results represent the means 
± SD of triplicates. 
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 Figure 3.11.2 Effect of Cytochalasin D, PI3 and MAP kinases inhibitors on 
Salmonella-induced NF-κB activation and IL-8 production. Cells were pretreated with 
the inhibitors at indicated concentrations with DMSO serving as negative control for one 
hour. The cells were subjected to infection at MOI of 100:1 before they were assayed for 
NF-κB (A) and IL-8 (B). Cyt D represents Cytochalasin D. Experiments were performed 




IL-8 serves as an important chemoattractant in recruiting leukocytes to the site where 
infection occurs. On the other hand, excessive amount of locally produced IL-8 can have 
deleterious effect on host tissues. Therefore, IL-8 gene expression is tightly controlled at 
several levels. In normal uninfected tissues, IL-8 is present at low, undetectable level as a 
result of transcriptional repression (Nourbakhsh and Hauser, 1999; Nourbakhsh et al., 
2001). Upon stimulation by cytokines or bacterial stimuli, NF-κB is activated and binds 
to IL-8 promoter containing NF-κB elements required to initiate gene transcription. 
Maximal IL-8 production also requires regulation by MAPK pathways. JNK and ERK 
pathways have been implicated in transcriptional activation of the gene and stabilization 
of the mRNA is mediated by the p38 MAPK pathway (Holtmann et al., 1999; Hoffmann 
et al., 2002). 
 In the in vitro system, B. pseudomallei-induced IL-8 was first described in lung 
epithelial cells, A549, which correlated with activation of NF-κB (Utaisincharoen et al., 
2004; Utaisincharoen et al., 2005). Cytochalasin D treatment did not interfere with IL-8 
production, IκB degradation or p38 phosphorylation (Utaisincharoen et al., 2004; 
Utaisincharoen et al., 2005), likely due to the involvement of surface PRR such as the 
TLR.  Contrary to their studies, our results using HEK293T cells show that B. 
pseudomallei induced NF-κB activation and IL-8 secretion can be blocked by 
cytochalasin D. Cytochalasin D is known to affect actin polymerization which is 
important in controlling bacterial entry. However, previous reports demonstrate that actin 
is also controlling intracellular transport of endosome which is important for activation of 
MAPK (Pol et al., 2000), as well as regulation of NF-κB transportation into the nucleus 
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(Mackenzie et al., 2006). In our studies, cytochalasin D neither abrogate NF-κB 
activation nor IL-8 induction in response to flagellin, an agonist to surface TLR5, 
implying cytochalasin D treatment does not impair the intracellular transport or signaling. 
Moreover, cytochalasin D–treated cells prevented B. pseudomallei entry. As HEK293T 
cells express negligible amounts of surface TLRs (Hornung et al., 2002), NF-κB 
activation and IL-8 secretion could occur in the TLR-independent manner. Supporting 
this, our NF-κB reporter gene in HEK293T cells could not be activated by TLR2, 4 and 5 
agonists unless the cells are co-transfected with the respective TLR plasmids. Moreover, 
NF-κB activation is not abolished by inhibiting MyD88. The requirement of bacterial 
internalization for NF-κB activation and IL-8 induction also excludes the participation of 
other cell surface receptors such as integrins but strongly suggests the involvement of 
leucine rich repeats-containing intracellular PRR such as NOD1 and NOD2. However, 
we found no contribution of NOD1 or NOD2 in NF-κB and IL-8 production.  
The differential IL-8 production seen in wild-type and bsaQ mutant could be due 
to transcriptional or post-transcriptional events of IL-8. Wild-type B. pseudomallei 
triggered higher level of IL-8 mRNA with time compared to bsaQ mutant with no 
differences in mRNA stability (data not shown) noted between the two. Hence, higher 
amount of IL-8 seen in the wild-type is contributed by greater IL-8 transcriptional 
activity. NF-κB is the key regulator of IL-8 gene expression and previously, we had 
observed a correlation between NF-κB activation and IL-8 production in our system. The 
IκB SR is mutated, preventing phosphorylation and activation and hence, serves as a NF-
kB inhibitor. Expectedly, IκB SR completely shut down NF-κB activation with a slight 
but significant reduction on IL-8 level. The results were consistent even with the highest 
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concentration of plasmids used where almost all the cells were shown to be transfected 
with the super-repressor. These results imply that NF-κB is only partially required for IL-
8 production. To minimize the chance that any observed results are due to non-
specificity, we employed another functionally unrelated inhibitor of NF-κB, MG132 
which is known to abrogate cytokine production (Gerber et al., 2004; Ortiz-Lazareno et 
al., 2008). Although MG132-treated cells only resulted in a 30 % decrease in NF-κB 
activation, the same extent of IL-8 reduction was observed. One plausible explanation for 
greater reduction of IL-8 than NF-κB could be that MG132 as a proteasome inhibitor also 
affects other cellular functions such as in regulation of protein metabolism in response to 
oxidative stress and cell cycle (Bader et al., 2007; DeMartino and Gillette, 2007) which 
influence overall functionality of the cells leading to less IL-8 being produced. Moreover, 
treatment with MG132 also contributes to cell death (Dolcet et al., 2006), which might 
explain the greater reduction in IL-8 production although inhibition of NF-κB is only 
minimal. Alternatively, it has been reported that proteasome inhibitors include MG132 
can cause alternate NF-kB activation pathway by activating upstream kinases responsible 
for this activation (Dolcet et al., 2006). These kinases phosphorylate p65 at serine 536 
and such phosphorylation ensures that its activation is independent of IκBα-proteasome 
pathway (Sasaki et al., 2005). Hence, the net effect of using MG132 as NF-κB inhibitor 
proves to be less effective since it also activates alternate NF-κB which is not observed 
with the use of IκB SR. It is not known however if such activation actually translates into 
IL-8 production and could possibly explain the lack of dependency of IL-8 induction on 
NF-κB level. 
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Compared to NF-κB, MAPK might contribute significantly to IL-8 production as 
others (Holtmann et al., 1999; Hoffmann et al., 2002) have found cross-talk between 
MAPK pathways with NF-κB and the modulation of NF-κB transactivation machinery. 
By using low concentrations of inhibitors to minimize non-specific effects, we show that 
IL-8 induction is greatly affected by p38, followed by JNK and then ERK inhibitors.  The 
inhibition of NF-κB by p38 and JNK inhibitors correlated closely with that of IL-8 
secretion with the exception of MEK1/2, which occurs upstream of ERK, showing a 
more severe attenuation in IL-8 secretion compared to NF-κB activation. These 
differences were attributed to our data showing both p38 and JNK but not ERK were 
involved in bacterial entry which was a prerequisite for bacterial-induced NF-κB 
activation. On the other hand, ERK inhibitors were able to block IL-8 production despite 
little reduction in NF-κB activation since IL-8 production is not solely controlled by NF-
κB. Further corroborating these findings, MAPK inhibitors could also effectively 
suppress transcription of IL-8.  
The mechanism on how the B. pseudomallei bsa TTSS contributes to NF-κB 
activation and IL-8 induction remains elusive. Previously, bopE and bipD mutants were 
demonstrated to be less able to invade HeLa cells (Stevens et al., 2003).  Moreover, both 
bipD and bsaZ mutants (Stevens et al., 2002) as well as a bsaU mutant (Pilatz et al., 
2006) were shown to be confined within endocytic vesicles.  However, in our system, 
bsaQ mutant was able to invade and replicate in epithelial cells as effectively as wild-
type. Furthermore, our bopE mutants, which have deletion in bopE also exhibited equal 
capability to invade. Furthermore, bsaQ mutant was not defective in vacuolar escape into 
the cytosol despite being unable to secrete BipD.  The seemingly contradictory results 
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could be due cell-type specific events or strain differences, as our strain is more invasive 
and no centrifugation of bacteria onto host cells is necessary for invasion, in contrast to 
what was reported (Stevens et al., 2003). However, a recent report by Burtnick et al. 
shows that bsaz mutant is capable to invade, replicate as well as escape from vesicles into 
the cytoplasm but these processes are delayed compared to the wild-type bacteria 
(Burtnick et al., 2008) which might explain why these phenomenon are not observed 
previously since the studies are conducted at earlier time-point. These findings further 
support our data demonstrating that bsa TTSS is not required for these cellular processes 
although no delay was observed in our case. The use of an independent bsaU mutant 
supports our interpretation that at least in our bacterial strain, the bsa TTSS, is important 
for IL-8 induction in HEK293T cells. Although all MAPK seems to be required for IL-8 
induction, only JNK and ERK are differentially activated by bsa TTSS with no 
differences in p38 MAPK activation. JNK was significantly upregulated at 120 minutes 
while ERK was downregulated at 90 minutes in wild-type compared to bsaQ mutant.  
Bacterial invasion was observed as early as 30 minutes hence it is not possible that JNK 
activation at these late time points control bacterial entry. Moreover, we have shown that 
the bsaQ mutant is equally invasive as the wild-type. Thus, apart from NF-κB, the high 
level of IL-8 production seen in the wild-type could be a net effect of more IL-8 
transcription mediated by JNK with little contribution from ERK since IL-8 production is 
not drastically abrogated with 10 μM of ERK inhibitors. It is important to note that in this 
study, we are unable to detect any MAPK activation during early time points of 10-30 
minutes after infection. This is easily explainable as the bacteria need to be internalized 
into the cells before activation of downstream signaling could occur. This process takes 
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time unlike the cell surface receptor interaction that could result in early activation of 
MAPK within minutes. 
  It is possible that B. pseudomallei, like other pathogenic strains, utilizes one or 
more unidentified TTSS effectors directly or indirectly to interact with adaptors in the 
NF-κB and the JNK pathways, although we can rule out the involvement of BopE as our 
bopE mutant behaved similarly as wild-type bacteria. For instance, intracellular 
Chlamydia trachomatis produces an unidentified growth-dependent factor which induces 
epithelial IL-8 through NF-κB (Bucholz and Stephens, 2006). P. aeruginosa has been 
shown to use the TTSS-secreted exotoxin U to activate JNK, resulting in phosphorylation 
of c-Jun and production of activated AP-1 transcription factor which regulate IL-8 
production (Cuzick et al., 2006).  Similarly, compared to H. pylori cag- strain, cag+ strain 
is a more potent inducer of all MAPK which is required for IL-8 production but has no 
effect on NF-κB activation (Keates et al., 1999).  At present, whether B. pseudomallei 
wild-type or mutant bacteria differentially activate AP-1 remains to be assessed as it has 
been demonstrated that P. aeruginosa-mediated IL-8 induction depends on MAPK but 
does not involve AP-1 (Delgado et al., 2006).  
The findings that B. pseudomallei entry is necessary and activation bypasses TLR 
and NOD receptors suggest a unique mechanism of IL-8 induction. In contrast to B. 
pseudomallei, intracellular Salmonella strains could activate HEK293T without the need 
to be internalized suggestives the involvement of surface receptors. Furthermore, only 
PI3K and p38 MAPK and not JNK inhibitor affect IL-8 induction. Although comparable 
NF-κB activation was seen between the two pathogens, B. pseudomallei seems to 
potentiate the production of IL-8 possibly through the activation of MAPK such as JNK 
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which is known to amplify transcriptional activity of IL-8 (Hoffmann et al., 2002).  One 
of the intriguing observations is that B. pseudomallei-induced IL-8 was so much lower 
compared to Salmonella in Caco-2 cells (chapter 2), contrary to HEK293T cells. This 
effect could be attributed to cell type variation as Salmonella is evolved to infect 
intestinal epithelial cells and less so with other cell types. As the mechanisms of IL-8 
induction vary between these two pathogens, it is also likely that the receptors required 
for IL-8 induction by Salmonella are quantitatively different on HEK293T and Caco-2 
cells. However, it remains to be determined whether a low IL-8 is indeed seen in all 
polarized epithelial cells derived from other mucosal surfaces by B. pseudomallei. 
In conclusion, we have found that B. pseudomallei utilizes bsa TTSS to activate 
NF-κB and MAPK contributing to epithelial IL-8 production. The induction of NF-κB 
and MAPK in the TLR independent manner may represent a mechanism whereby B. 
pseudomallei initiates inflammation when it first encounters the epithelium, where TLR 
expression is low and compartmentalized (Abreu et al., 2001; Gewirtz et al., 2001; 
Melmed et al., 2003), possibly explaining the differential IL-8 induction seen between 
the wild-type and bsaQ mutant in polarizable Caco-2 epithelial cells (chapter 2). 
Moreover, B. pseudomallei does not seem to activate NOD although NOD receptors have 
recently been implicated as a major bacterial sensing receptor in epithelial cells 
(Travassos et al., 2005; Zilbauer et al., 2007). Nevertheless, B. pseudomallei TTSS-
dependent IL-8 induction is masked once the TLRs are present. For example when non-
polarizable lung epithelial A549 cells were infected with wild-type and TTSS mutant, 
they do not exhibit differential IL-8 induction (data not shown). Moreover, we have 
demonstrated that bsaQ mutant is not defective in its ability to activate TLR (chapter 4). 
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Although IL-8 induction may be beneficial to the host, uncontrolled induction 
could prove detrimental. Excessive extravasation by neutrophils was demonstrated to 
mediate tissue damage and increase epithelial permeability. This has been significantly 
demonstrated in epithelial cells infected with Shigella flexneri whereby neutrophils 
mediate epithelial injury following infection to facilitate spreading of bacteria into the 
basolateral site of epithelial (Perdomo et al., 1994; Sansonetti et al., 1999).  Likewise, C. 
difficile’s toxin A induces p38 MAPK activation and IL-8 production, contributing to 
intestinal inflammation and mucosal damage (Warny et al., 2000).  Reported in a case 
study involving melioidosis patients, fifty percent of patients who died from melioidosis 
had detectable plasma IL-8 but not TNF-α concentration (Friedland et al., 1992), 
suggesting a potential pathophysiological role of IL-8. It is plausible that the induction of 
IL-8 by B. pseudomallei could cause greater epithelial injury allowing bacterial invasion 





















































Toll-like receptors are the major signaling receptors that play a critical role in innate 
immune response by translating early recognition of bacterial components into the 
induction of various immune effectors. The induction of these effectors such as 
cytokines, chemokines, antimicrobial peptides and ROS is pathogen context-dependent 
because each of these TLRs mediates recognition of different invariant pathogen ligands. 
Individual or combined signals from TLRs generate specific immune effectors which are 
tailored to combat different invading pathogens. The specificity of TLR signaling is 
achieved partly through recruitment of a combination of adaptor proteins MyD88, MAL, 
TRIF and TRAM, together with other common downstream signaling molecules such as 
IRAK1, IRAK4, TRAF6 and TAK, leading to activation of transcription factor NF-κB 
(Kawai and Akira, 2007; Lee and Kim, 2007). Furthermore, activation of different 
MAPK by various TLR-ligand stimulations can control the regulation of various 
transcription factors, affecting the type of responses elicited. This confers another level of 
specificity to the interaction.  
While live B. pseudomallei infection had been shown to stimulate production of 
proinflammatory cytokines and chemokines from epithelial cells as well as macrophages, 
to date, no one has directly demonstrated the upstream receptors responsible for this 
induction. In our previous studies using HEK293T cell line, we demonstrated that B. 
pseudomallei was capable of activating NF-κB to produce IL-8 in the process which was 
independent of TLR but required bacterial invasion and intact bsa TTSS.  This is in 
contrast to Utaisincharoen et al. who reported that preventing bacterial entry by 
cytochalasin D does not interfere with IL-8 production nor IκBα degradation in A549 
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epithelial cells, implying the involvement of surface receptors (Utaisincharoen et al., 
2004 and 2005). Recently, Wiersinga et al. described the interaction of B. pseudomallei 
with TLRs. While whole bacteria can activate TLR4, the ligand responsible is not LPS. 
They claimed that B. pseudomallei LPS signals via TLR2 instead of TLR4. Moreover, 
signaling through TLR2 causes massive inflammation and is beneficial to bacterial 
survival and detrimental to the host (Wiersinga et al., 2007). It remains a possibility that 
other TLRs are also involved as it has been shown that B. pseudomallei possesses 
flagellin which is the ligand for TLR5 (Kawahara et al., 1992; Chua et al., 2003).  In the 
previous chapter, we have demonstrated that the HEK293T cell line expresses a 
negligible amount of surface or endogeneous expression of TLRs except for TLR5 which 
is in accord with other report (Hornung et al., 2002). Upon transfection with TLRs, 
HEK293T cells became responsive to the respective TLR ligands.  Using the TLR-
transfected HEK293T system, we examined B. pseudomallei interaction with various 
TLRs.  
The role of TLRs is not restricted to innate immunity as TLRs also help to shape 
an optimal adaptive immune response. The effect of TLRs on the activation of adaptive 
immunity is mediated through several mechanisms including maturation of antigen 
presenting cells, induction of expression of cytokines and co-stimulatory molecules and 
reversal of tolerance.  Given the importance of TLRs in immune response, many 
pathogens have targeted TLRs and its signaling machinery for modification to suppress 
or evade the immune response. One example of pathogens which directly modulate TLR-
ligand interaction is Salmonella, which modifies TLR4 agonist, lipid A by deacylation, 
hence reducing the proinflammatory potential (Kawasaki et al., 2004). Pseudomonas 
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species can also modify the structure of lipid A through addition of ethanoloamine, 
aminoarabinose and palmitate moieties to resist recognition and killing (Hajjar et al., 
2002). Treponema spirochetes exhibits a totally different evasion mechanism through its 
glycoconjugate by blocking LPS binding to its co-receptors, LPS-binding protein and 
CD14 (Asai et al., 2003). Since LPS-TLR4 activation induces nitric oxide production in 
murine macrophages, blocking its initial interactions may contribute to better survival of 
Treponema. Pathogen such as Vaccinia virus blocks TLR-mediated signaling by targeting 
viral protein A54R to IRAK2 and TRAF6, two key proteins in the TLR signaling 
pathway required for NF-κB activation (Harte et al., 2003). Likewise, Yersinia YopJ 
appears to modulate several intermediates along TLR signaling by acting as 
deubiquitinase on TRAF2, TRAF6 and IкBα, thus preventing NF-κB activation (Zhou et 
al., 2005). While most pathogens seem to block TLR-mediated signal transduction to 
blunt immune effector production, Yersinia pestis secretes the protein effector LcrV, 
which is capable of mimicking the activity of a eukaryotic protein by interacting with 
TLR2, activating NF-κB to secrete IL-10 (Sing et al., 2002). Production of anti-
inflammatory cytokine IL-10 suppresses the production of proinflammatory cytokine 
which is required for bacterial containment.  
Although it has been shown that B. pseudomallei possesses many strategies to 
evade the innate immune responses, there is no evidence of B. pseudomallei subversion 
of the TLR signaling pathway. As many microbial pathogens have utilized the TTSS to 
exploit TLR signaling, it is plausible that B. pseudomallei may employ similar 
mechanisms of evasion. In this study, we investigated the contribution of B. pseudomallei 
bsa TTSS in suppressing TLR-mediated NF-κB activation by comparing the ability of B. 
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pseudomallei wild-type strain KHW and bsaQ mutant in their ability to activate TLR. 
Additionally, we also compare the ability of KHW and bsaQ mutant in suppressing NF-
κB activation by cytokines (IL-1 and TNF-α) and overexpression of TLR signaling 
intermediates. As important as the TLR family is to innate immune responses, 
dysregulation of these receptors can also have an adverse effect in generation of an 
effective immune response. Such information not only gives us better insights into 
pathogenicity of B. pseudomallei but might also prove to be useful when it comes to 
vaccine design.   
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Bacterial strains 
 
In this study, all bacterial strains and preparation of log-phase bacteria and heat-
inactivated bacteria were performed as described in chapter 2 and chapter 3.  
 
4.2.2 Cell-line 
HEK293T cell line used in this study was maintained as described in chapter 3. 
 
 
4.2.3 Plasmids  
TLR2, TLR4, MD2, CD14, TLR5, MyD88, TRAF6 and two luciferase reporter plasmids, 
p5xNF-κB-luc (Stratagene, La Jolla, CA) and pRL-CMV (Promega, Madison, WI) were 
kind gifts from gifts from Dr. Lu Jinhua, National University of Singapore. The 
sequences of the respective plasmids were amplified from human monocytes as described 
previously (Zhang et al., 2002) and all were cloned into the BamHI/ApaI site of the 
pcDNA3.1 myc/His vector (Invitrogen).  IKK and TRIF plasmids were purchased from 
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Mammalian Gene Collection while p65 plasmid (Stein and Baldwin, 1993) was a kind 
gift from Dr. Baldwin A, University of North Carolina, Chapel Hill.  All the plasmids 
were purified with HiSpeed Plasmid Midi Kit (Qiagen GmbH, Germany) according to 
manufacturer’s protocol.  
 
4.2.4 Detection of NF-κB activation 
NF-κB activation was measured as previously described in Chapter 2 and 3. After 2.5 x 
105 HEK293T cells were seeded overnight, the cells were transfected with two luciferase 
reporter plasmids and TLR plasmids at a total plasmid amount of 0.5 μg/well. For the 
overexpression system, the amounts of plasmids transfected varied and are specified in 
the figure legends. As negative controls, the cells were transfected with the pcDNA3.1 
vector. After 24 hours, the cells were infected with bacteria at MOIs of 100:1 and 10:1 in 
antibiotic-free medium. After 2 hour of infection, 40 μg/ml of tetracycline was added and 
cells were further cultured for 5 hours. NF-κB activation was assayed as described in 
chapter 2. NF-κB activation was expressed as a ratio of Firefly luciferase activity over 
Renilla luciferase activity or fold increase in NF-κB activation of TLR- relative to 
pcDNA- transfected HEK293T cells infected with bacteria.  
 
4.2.5 Stimulation of HEK293T cells 
To investigate the ability of bacteria to suppress TLR agonist-induced NF-κB activation, 
transfected cells were simultaneously infected with bacteria as before and co-stimulated 
with TLR ligands; TLR2 agonist, Pam3Csk4  (Invivogen) at 1 μg/ml, TLR4 agonist,  
ultrapure LPS (Invivogen) at 1 μg/ml and TLR5 agonist, flagellin (purified as described 
in Chapter 2) at 500 ng/ml. Similarly, to examine the ability of bacteria to suppress 
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cytokine-induced NF-κB activation, cells were co-stimulated with either IL-1 (kind gifts 
from Dr. Lu Jinhua, NUS) or TNF-α at 20 ng/ml.  To examine the effect of bacterial 
invasion in this study, cells were pretreated with cytochalasin D (Sigma) at 2 μg/ml one 




4.3.1 Comparison of live and heat-inactivated B. pseudomallei, B. thailandensis and 
E. coli in TLR-induced NF-κB activation 
We used HEK293T cells which were transfected with an individual TLR and a NF-κB 
luciferase reporter to examine which TLRs were activated upon infection by B. 
pseudomallei. Live B. pseudomallei was shown to activate TLR2, TLR4 together with its 
co-receptors (MD2, CD14) and TLR5 in comparison to pcDNA-transfected cells, which 
do not express any TLR (Fig. 4.1.1A and B). It is not surprising that B pseudomallei 
could activate TLR4/MD2/CD14 and TLR5 because its respective ligands, LPS and 
flagellin have been shown present in the bacterium (Kawahara et al., 1992; Chua et al., 
2003). The ability of B. pseudomallei to activate TLR2, suggests existence of TLR2 
ligands, possibly lipoprotein. Heat treatment did not affect the ability of bacteria 
components to be recognized by its respective receptors since heat-inactivated B. 
pseudomallei still exhibited stimulatory potential. This is in agreement with the notion 
that LPS and lipoprotein are naturally more resistant to heat treatment and while flagellin 
protein conformation may be affected upon heating, it still retains the intact epitope (13 
amino acids) which is recognizable by TLR5 (Smith et al., 2003).  
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In the pcDNA-transfected cells, live B. pseudomallei activated NF-κB up to 4-
fold higher compared to heat-inactivated B. pseudomallei (Fig. 4.1.1A). However, in the 
TLR2, TLR4/MD2/CD14 and TLR5-transfected cells, live bacteria only showed a 2-fold 
increase in NF-κB activation compared to a 4-7 fold increase by heat-inactivated bacteria 
(Fig. 4.1.1B). The avirulent B. thailandensis also activated TLRs. Like B. pseudomallei, 
heat-inactivated B. thailandesis also exhibited higher level of NF-κB attributed to these 
TLRs (Fig. 4.1.1C and D).  One possible explanation for such phenomenon could be 
attributed to liberation of more TLR agonists upon heat-treatment compared to intact 
bacteria. However, if this hypothesis is correct, heat-inactivated E. coli should exhibit 
higher level of nuclear response relative to live bacteria, which was not supported by 
Figures 4.1.1E and F. Alternatively, there could be an active mechanism present in live 
bacteria that suppress TLR-induced NF-κB activation. It is likely that this mechanism is 
only adopted by pathogenic bacteria such B. pseudomallei but not non-pathogenic E. coli 
strain. It has to be noted that although avirulent live B. thailandensis also exhibit reduced 
TLR activation compared to heat-killed bacteria, the level of inhibition is much lower 




Figure 4.1.1 Comparison of heat-killed and live B. pseudomallei, B. thailandensis 
and E. coli in TLR-induced NF-κB activation. HEK293T cells transfected with 
respective TLRs and pcDNA (control plasmid) were stimulated with either heat-killed 
(HK) or live bacteria at MOI of 100:1 for 7 hours. NF-κB activation was expressed as a 
ratio of Firefly over Renilla luciferase activity (left panel) or fold increase in NF-κB 
activation relative to control pcDNA-HEK293T stimulated cells (right panel). KHW 
denotes wild-type B. pseudomallei (A, B), BT denotes B. thailandensis (C, D) and EC 
denotes E. coli (E, F). Results represent the means ± SD from triplicates and are 
representative of the two separate experiments. 
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4.3.2 B. pseudomallei bsa TTSS is required for reduced TLR2, 4 and 5-induced NF-
κB activation 
We found that wild-type live B. pseudomallei activated TLR2, TLR5 and 
TLR4/MD2/CD14 weakly in comparison to heat-inactivated B. pseudomallei. We suspect 
the existence of active mechanisms in live bacteria that help them to suppress TLR 
signaling. Many reports have demonstrated that pathogenic bacteria subvert TLR 
signaling pathways via their TTSS effectors (Zhou et al., 2005; Sweet et al., 2007) or 
other non-TTSS effectors which require the function of TTSS-dependent translocation 
(Hauf and Chakraborty, 2003; Ruchaud-Sparagano et al., 2007) into host cells. To assess 
the necessity of an intact bsa TTSS in mediating such an effect, we compared wild-type 
B. pseudomallei (strain KHW) and bsa TTSS mutant in their ability to activate TLRs. It 
is important to note that in order to compare the activation by wild-type to bsaQ mutant, 
one has to determine the fold increase of TLR-transfected value divided by the control 
pcDNA-transfected value rather than the absolute luciferase activity. This is due to the 
higher background in NF-κB activation by wild-type bacteria even in pcDNA-transfected 
cells compared to the bsaQ mutant. In the previous chapter, we had shown that the bsaQ 
mutant, unlike KHW, could not activate NF-κB in a TLR-independent manner. However, 
when HEK293T cells transfected with TLR2, TLR4/MD2/CD14 and TLR5 were 
stimulated with the bsaQ mutant, the bacteria exhibited increased NF-κB activation 
compared to KHW (Fig. 4.2.1A-F). At MOI of 100:1, more than 50 % increase in NF-κB 
activation via TLR2, TLR4/MD2/CD14 and TLR5 was observed with the bsaQ mutant 
compared to wild-type bacteria. Lowering MOI from 100 to 10 further increased the level 
of NF-κB activation, suggesting that this suppression effect was dose dependent. 
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Presumably, at lower bacteria load, fewer bacteria can exert their suppressive effect on 
TLRs, hence higher level of nuclear response was seen. This effect was not observed with 
TLR4 transfection alone pointing to the specificity of this interaction (Fig. 4.2.1G and H). 
Unlike the bsaQ mutant, bopE mutant, which has deletion in the TTSS effector bopE 




Figure 4.2.1 B. pseudomallei bsa TTSS is required for reduced TLR-induced NF-κB 
activation. HEK293T cells transfected with TLR2 (A, B),  TLR4/MD2/CD14 (C, D), 
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TLR5 (E, F), TLR4 (G, H) and pcDNA as plasmid control overnight before the cells were 
infected with KHW or bsaQ mutant at MOI of 100:1 for 7 hours. NI denotes non-infected 
cells.  NF-κB activation was expressed as ratio of Firefly over Renilla luciferase activity 
(left panel) or fold increase in NF-κB activation of TLR- relative to pcDNA-transfected 
HEK293T infected with bacteria (right panel). Experiments were performed two times 
and results represent the means ± SD from triplicates. 
 
 
Figure 4.2.2 BopE is not required to suppress TLR-induced NF-κB activation. 
HEK293T cells transfected with respective TLR were infected with bacteria at MOI of 
100:1 for 7 hours. NF-κB activation was expressed as ratio of Firefly over Renilla 
luciferase activity (A) or fold increase in NF-κB activation of TLR-transfected relative to 
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pcDNA-HEK293T infected cells (B). Experiments were repeated two times and results 
represent the means ± SD from triplicates. 
 
4.3.3 Internalization of bacteria is required for reduced TLR2, 4 and 5-induced NF-
κB activation 
Cytochalasin D inhibits actin polymerization and has been shown to inhibit bacterial 
invasion into mammalian cells. To determine if bacterial internalization is required for 
suppression, cells were pretreated with 2 μg/ml of cytochalasin D one hour before 
infection. Addition of cytochalasin D prevented activation of nuclear response in cells 
transfected with pcDNA when stimulated with KHW but had little effect on cells 
stimulated with bsaQ mutant. However, cytochalasin D did not affect the level of NF-κB 
activation due to TLR2, TLR4/MD2/CD14 and TLR5 in the cells infected with KHW 
(Fig. 4.3.1A-F). Hence, it seems that by preventing bacterial entry, KHW-induced TLR 
suppression was relieved.  Surprisingly, inhibiting bacterial internalization by bsaQ 
mutant further increased the level of NF-κB activation by at least 50 % more in bsaQ 
infected cells in the presence of TLRs. This indicates that there is also some level of 
suppression by the bsaQ mutant and this suppression is relieved by inhibiting 
internalization (Fig. 4.3.1A-F). Our results suggest that one of the mechanisms of 
suppression requires internalization but not bsa TTSS and another mechanism relies on 





Figure 4.3.1 Bacterial invasion is required for reduced TLR-induced NF-κB 
activation. HEK293T cells transfected with TLR2 (A, B), TLR4/MD2/CD14 (C, D), 
TLR5 (E, F), TLR4 (G, H) and pcDNA as plasmid control. To examine the effect 
bacterial invasion, the cells were pretreated with cytochalasin D (Cyt D) at 2 μg/ml one 
 138
hour before infection with KHW or bsaQ mutant at MOI of 100:1 for 7 hours. NI denotes 
non-infected cells.  NF-κB activation was expressed as ratio of Firefly over Renilla 
luciferase activity (left panel) or fold increase in NF-κB activation of TLR- relative to 
pcDNA-HEK293T which were infected with bacteria (right panel). Results represent the 
means ± SD from triplicates and are representative of the two separate experiments. 
 
4.3.4 B. pseudomallei  bsa TTSS is required to suppress activation of TLR2, TLR4 
and TLR5 agonists-induced NF-κB activation 
We further compared KHW and bsaQ mutant in their ability to suppress TLR2 
(Pam3Csk4), TLR4 (LPS) and TLR5 (flagellin) agonists-induced NF-κB activation. As 
shown in Figure 4.4.1A, both KHW and bsaQ suppressed Pam3Csk4-induced NF-κB 
activation in the absence of cytochalasin D although less so with bsaQ mutant. In the 
cytochalasin D-treated cells, suppression of Pam3Csk4 activation was completely relieved 
in bsaQ mutant although only partially with KHW at higher MOI (100:1). As for the 
TLR4 and TLR5 studies, we observed that both KHW and bsaQ mutant suppressed NF-
κB activation regardless whether cytochalasin D is present and absent (Fig. 4.4.1C-F).  
These results show that for TLR4 and TLR5 stimulation, suppression is partially relieved 
when bacteria are prevented from entry. Additional suppression mechanisms independent 





Figure 4.4.1 B. pseudomallei invasion and intact bsa TTSS are required for 
suppression of TLR agonist-induced NF-κB activation. HEK293T cells transfected 
with TLR2 (A, B), TLR4/MD2/CD14 (C, D), TLR5 (E, F) and pcDNA (control plasmid) 
overnight before the cells were simultaneously stimulated with KHW or bsaQ mutant at 
MOI of 100:1 and 10:1 and with TLR agonists; Pam (TLR2 agonist) = Pam3Csk4 (1 
μg/ml), LPS (TLR4 agonist) = ultrapure LPS (1 μg/ml) and Flg (TLR5 agonist) = 
flagellin (500 ng/ml). (B, D, F) To investigate if bacterial invasion is required, the cells 
were treated with cytochalasin D (2 μg/ml) one hour before infection. The ability of 
KHW or bsaQ mutant to suppress TLR agonist-induced NF-κB activation was compared 
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to cells treated with agonists alone. Results were expressed as fold increase of TLR- 
relative to pcDNA-HEK293T cells treated either with agonist alone or a combination of 
agonist and bacteria. Results are means of triplicates and are representative of two 
separate experiments. 
 
4.3.5 B. pseudomallei bsa TTSS is required to suppress activation of IL-1 and TNF-
α-induced NF-κB activation 
The ability of B. pseudomallei to suppress TLR2, TLR4 and TLR5 suggests that the 
suppression may occur downstream from surface TLR activation and likely involves 
signaling intermediates common to these TLRs. Ligation of all TLRs (except TLR3) 
recruits adaptor, MyD88 to the cytoplasmic portion of the receptor and activation of 
series of intermediates such as IRAK4, IRAK1, TRAF6 and TAK which subsequently 
leads to NF-κB activation (Kawai and Akira, 2007; Lee and Kim, 2007). This pathway is 
also shared by IL-1 which signals via IL-1 receptor (Orlinick and Chao, 1998; Chen and 
Goeddel, 2002). To rule out that the inhibition mechanism is at the level of TLR, we 
examined if B. pseudomallei could suppress IL-1 stimulated NF-κB activation. Figure 
4.5.1A shows that KHW suppressed ~ 70 % IL-1 activation depending on bacterial 
MOIs. Similar to previous data, the level of inhibition by bsaQ mutant was lower 
compared to KHW. Aside from IL-1, TNF-α-TNFR interaction also induces nuclear 
response. This signaling pathway however is distinct from that of IL-1 because it is 
mediated by TRADD, TRAF2 and TRAF5 (Chen and Goeddel, 2002). Even so, as shown 
in Figure 4.5.1B, KHW to lesser extent, bsaQ mutant was still able to suppress activation 
of NF-κB in a dose-dependent manner. Combining all the data, it implies that B. 
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pseudomallei TTSS-dependent and -independent factors could target the inhibition 
possibly at or downstream of IKK, which is common to these two signaling pathways.  
 
Figure 4.5.1 B. pseudomallei bsa TTSS is required to suppress IL-1 and TNF-α 
induced NF-κB activation. HEK293T cells transfected with luciferase reporters were 
simultaneously stimulated with either (A) IL-1 at 20 ng/ml or (B) TNF-α at 20 ng/ml and 
infected with KHW or bsaQ mutant at MOIs of 100:1 and 10:1 for 7 hours. NI refers to 
cells that are not infected with bacteria. For ease of comparison, results are expressed as 
fold increase in NF-κB activation of either cells treated with bacteria and cytokine 
relative to bacteria alone or cells treated with cytokine relative to non-stimulated cells. 
Results represent means of triplicates and are representative of two separate experiments. 
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4.3.6 B. pseudomallei bsa TTSS is required to suppress activation of NF-κB induced 
by overexpression of signaling intermediates in TLR signaling pathways 
The signaling pathway from the activation of TLR to NF-κB occurs through the 
recruitment of MyD88, followed by IRAKs, TRAF6, TAK and IKK which in turn 
releases bound IκB from NF-κB, thus releasing an active NF-κB to translocate into the 
nucleus (Kawai and Akira, 2007; Lee and Kim, 2007). To investigate the potential targets 
of suppression along the TLR signaling pathway, we compared the ability of KHW and 
bsaQ mutant to inhibit NF-κB by overexpression of selective signaling molecules along 
the TLR signaling pathway.  Figure 4.6.1A shows KHW inhibited 80 % of NF-κB 
activation due to overexpression of MyD88 in comparison to less than 20 % by bsaQ 
mutant, which is consistent with previous data on IL-1 inhibition, as the modulation is not 
exclusive to specific TLRs.  B. pseudomallei was also able to suppress TRAF6 and IKK 
(~75 %) which is downstream of MyD88 when compared to bsaQ mutant (~ 20 %) (Fig. 
4.6.1B and C) suggesting that the target could either be at the level of either IKK 
activation or at NF-κB activation and translocation into the nucleus. We tested if the 
bacteria could inhibit overexpression of p65 as it is one of the subunits of the 
heterodimeric NF-κB complex with the transactivation domain necessary for gene 
transcription (Karin and Ben-Neriah, 2000). The ability of KHW to suppress p65 
activation compared to bsaQ mutant (Fig. 4.6.1D) shows that suppression is at the level 
of the p65 subunit, affecting either its translocation into the nucleus or binding to the 
target DNA. KHW also inhibited TRIF activation (Fig. 4.6.1E) even though TRIF 
activates NF-κB through different intermediates from the canonical TLR pathway, which 




Figure 4.6.1 B. pseudomallei bsa TTSS is required to suppress overexpression of 
components of TLR signaling pathway. HEK293T cells were transfected with 
respective plasmids; (A) MyD88 at 1 μg/well, (B) TRAF6 at 1.5 μg/well, (C) IKK at 0.5 
μg/well, (D) p65 at 0.5 μg/well and (F) TRIF at 0.5 μg/well before the cells were infected 
for 7 hours with either KHW or bsaQ mutant at MOI of 100:1. Results were expressed as 
fold increase in NF-κB activation of signaling components-transfected relative to 
pcDNA-transfected cells infected with bacteria.  Experiments were performed twice and 
results represent the means of triplicates. 
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4.4 DISCUSSION 
Toll-like receptors are one of the most important pathogen recognition receptors in innate 
immunity that translate early recognition of microbial patterns into complex downstream 
signaling cascades contributing to active transcription factor NF-κB. Although B. 
pseudomallei infection is characterized by massive inflammation, the receptors involved 
have remained undefined until recently where TLRs are implicated in inflammatory 
cytokine production in B. pseudomallei infection (Wiersinga et al., 2007). Use of 
HEK293T cells that do not contain surface or endogenous TLRs (Hornung et al., 2002), 
revealed that B. pseudomallei was able to elicit IL-8 production via NF-κB and MAPK 
pathways (chapter 3). To explore the interaction of B. pseudomallei with TLRs, we 
examined NF-κB activation in HEK293T cells transfected with respective TLRs and 
reporter plasmids following infection by B. pseudomallei. As B. pseudomallei contains 
lipopolysaccharide and flagellin, it is not surprising that the bacteria could activate 
TLR4/MD2/CD14 and TLR5 which are receptors for the respective ligands. However, B. 
pseudomallei was also capable of activating TLR2 through ligands such as lipoprotein, 
likely a diacylated lipopeptide since it can signal directly through TLR2 without the 
presence of coreceptors, TLR1 and TLR6 (Buwitt-Beckmann et al., 2005). B. 
pseudomallei lipopolysaccharide is reported to signal via TLR2 instead of TLR4 in the 
presence of CD14 (Wiersinga et al., 2007) which is in accordance with others 
demonstrating the responsiveness of TLR2 to LPS only in the presence of CD14 
(Kirschning et al., 1998; Yang et al., 1998). However, what is questionable is whether B. 
pseudomallei LPS is truly unresponsive to TLR4 given that only cells expressing TLR4 
and CD14 are used (Wiersinga et al., 2007). While CD14, a 55-kDa 
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glycosylphosphatidylinositol-linked protein, functions in a dispensable manner as an 
enhancer for TLR2 and TLR4 responses to their respective ligands, peptidoglycan and 
LPS (Pugin et al., 1994; Jia et al., 2004), there is an absolute requirement for MD2 to 
associate with TLR4 conferring responsiveness of the receptor to LPS (Shimazu et al., 
1999; Jia et al., 2004; Fitzgerald et al., 2004). In our system, neither whole B. 
pseudomallei nor LPS (data not shown) can activate TLR4 without the presence of the 
coreceptors, MD2 and CD14 (Jia et al., 2004; Fitzgerald et al., 2004).  TLR9, which 
recognizes methylated DNA from bacteria, is not activated by B. pseudomallei (data not 
shown). One plausible explanation could be that intracellularly localized TLR9 might 
require some degree of bacterial processing, which occurs poorly in epithelial cells. 
Hence, we cannot eliminate the possibility that immune effector production mediated by 
TLR9 can still occur in macrophages infected with B. pseudomallei.  
Emerging evidence indicates that the high fidelity TLR-mediated pattern 
recognition signaling has become an important target of exploitation by many pathogens. 
Some pathogens adapt themselves by modifying the ligand such as lipid A by acylation 
(Kawasaki et al., 2004) or through addition of moieties (Hajjar et al., 2002) to 
downregulate the recognition and proinflammatory potential. Others can suppress host 
response by introducing effectors directly into host cells to modulate TLR signaling 
pathway (Harte et al., 2003; Zhou et al., 2005).  In fact, the unusual LPS of B. 
pseudomallei characterized by long-fatty acids and the acid-stable inner core region 
attached to lipid (Kawahara et al., 1992) is reported to be less pyrogenic and less 
stimulatory compared to LPS from other Gram-negative bacteria (Matsuura et al., 1996; 
Utaisincharoen et al., 2000). Presumably this unique characteristic of LPS represents an 
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avoidance mechanism of the bacteria from host immune response. Interestingly, a low 
production of IL-8 is also observed in epithelial cells infected with B. pseudomallei 
compared to S. typhi, with a correspondingly slower degree of IκB degradation 
(Utaisincharoen et al., 2004).  Although the unusual LPS structure could be one 
contributing factor, it is likely that B. pseudomallei possesses the capability to manipulate 
host signaling. Supporting this is work by Ekchariyawat et al. who demonstrated that B. 
pseudomallei can upregulate SOCS3 and CIS, which negatively regulate IFN-γ signaling 
thus interfering with the ability of the host cells to activate iNOS to kill the bacteria 
(Ekchariyawat et al., 2005).  
Our studies comparing the ability of heat-inactivated versus live B. pseudomallei 
to activate TLRs revealed that pathogenic B. pseudomallei may have evolved ways to 
subvert TLR activation. Heat-treated bacteria activated 50 % more NF-κB in cells 
transfected with TLR2, TLR4/MD2/CD14 and TLR5 compared to live bacteria. Heat-
inactivated and live E.coli activated all TLRs at a similar level eliminating the possibility 
that the higher stimulatory activity exhibited by heat-inactivated bacteria was due to 
release of sequestered microbial pattern upon heat treatment. Interestingly, the avirulent 
B. thailandensis also suppressed TLR although the level of suppression was lower than B. 
pseudomallei. To date, the most prevalent view about the origin of B. thailandensis and 
B. pseudomallei is that these bacteria might have evolved from a common ancestor, 
probably a soil saprophyte. Hence, it is conceivable that B. thailandensis might share the 
same virulence determinants as that of B. pseudomallei. In fact, it has been shown that the 
virulence factor, bsa TTSS found in B. pseudomallei is also highly conserved in B. 
thailandensis (Kim et al., 2005b). The avirulent property of B thailandensis is owing to 
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the presence of arabinose assimilation operon which has been shown to have 
antivirulence property. Unlike B. thailandensis, this operon has been deleted in B. 
pseudomallei, which contributes to evolution of this bacterium as pathogen (Moore et al., 
2004).  
It is evident from previous reports that many of the pathogenic microbes utilize 
TTSS to subvert TLR signaling. While microbes like Yersinia, Salmonella and Shigella 
target their TTSS effectors directly into host cells for immune subversion (Orth et al. 
2000; Collier-Hyams et al., 2002; Kim et al., 2005a; Zhou et al., 2005; Haraga and 
Miller, 2006), some exemplified by pathogenic E. coli actually targets non-LEE encoded 
effectors but nevertheless requires an intact TTSS delivery system for suppression (Hauf 
and Chakraborty, 2003; Ruchaud-Sparagano et al., 2007). To explore the possibility that 
B. pseudomallei TTSS is required to suppress TLR, we compared B. pseudomallei, wild-
type and TTSS deficient, bsaQ mutant in their ability to activate TLRs.  Consistent with 
others, we have also observed that intact B. pseudomallei bsa TTSS was involved in TLR 
suppression. bsaQ mutant activated at least 50 % more NF-κB in TLR2, 4 and 5- 
transfected cells relative to KHW and this effect was dependent on the bacterial dosage. 
With a lower bacterial load, less suppressive effect was exerted and hence, higher TLR 
activation was noted. Likewise, KHW, and to a lesser extent bsaQ mutant also 
suppressed TLR2, TLR4 and TLR5 agonists-stimulated NF-κB activation. Unlike the 
bsaQ mutant, the bopE mutant was not capable of suppressing TLR. This further 
demonstrates that the ability of B. pseudomallei to suppress TLR is not an artifact and 
also eliminates the likelihood of BopE as the TTSS effector involved. Furthermore, cell 
death was not observed during the course of infection that could possibly contribute to 
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the differential NF-κB activation induced by wild-type and mutant bacteria.  One might 
also argue that bsa TTSS might alter the metabolisms or the transcriptional/translational 
machinery in the cells infected with wild-type but not mutant bacteria leading to the 
differences.  But it is highly unlikely since we are using the dual luciferase reporter assay 
system which contains two luciferase reporter enzymes that are expressed simultaneously 
in each cell. The experimental reporter correlates with effect of the bacteria on NF-κB 
activity in the cells while the constitutive reporter providing internal control serving as 
baseline response. By normalizing the experimental reporter to constitutive reporter, we 
counter variability attributed to cell viability, transfection efficiency and overall 
funtionality of the cells.  Further confirmation regarding the metabolic state of the cells 
infected with both bacterial strains can be determined with MTT assay since this assay 
depends on mitochondrial enzyme which is only present in metabolically active cells to 
reduce the MTT substrate. To determine if there is any defect in transcriptional/ 
translation activity in the cells, the cells can be transfected with plasmid containing 
constitutive promoter, CMV linking either to luciferase enzyme or GFP when the cells 
are infected with the bacteria. Neither luciferase activity nor GFP expression should 
differ in cells infected with both strains if the transcriptional/ translational activities are 
not compromised.  
Different bacteria utilize varying mechanisms to inhibit TLR activation. Whereas 
some bacteria directly prevent recognition by receptors through their modified ligands 
(Hajjar et al., 2002; Kawasaki et al., 2004), some can interfere with the intracellular 
signaling pathways (Harte et al., 2003; Zhou et al., 2005). To identify the potential target 
of suppression, we examined the ability of bacteria to suppress cytokine-induced NF-κB 
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activation. IL-1 (Sims et al., 1993; Auron, 1998) and TNF-α (Vandenabeele et al., 1995; 
Baker and Reddy, 1998; Orlinick and Chao, 1998; Chen and Goeddel, 2002) are two 
cytokines known to provoke nuclear response via IL-1R and TNFR, respectively. Unlike 
TLRs and IL-1R which share the same intracellular TIR domain and hence signaling 
pathway (Kawai and Akira, 2007), TNFR signals through different intermediates, mainly 
TRADD and TRAF2 (Vandenabeele et al., 1995; Baker and Reddy, 1998; Orlinick and 
Chao, 1998; Chen and Goeddel, 2002). Since our results show that KHW and to lesser 
extent bsaQ mutant suppressed both IL-1 and TNF-α, it implies that B. pseudomallei 
TTSS dependent subversion could not act at the level of surface receptor but possibly at 
the level of IKK which is shared by both pathways. To further corroborate this 
observation, we tested the ability of KHW and bsaQ mutant to suppress overexpression 
of a series of signaling intermediates functioning at different levels in the TLR pathway. 
In TLR signaling, MyD88 represents the topmost intermediate after TLR engagement, 
followed by activation of IRAK, TRAF6 and IKK, leading to active NF-κB which needs 
to be translocated into the nucleus for gene transcription (Kawai and Akira, 2007; Lee 
and Kim, 2007). NF-κB consists as heterodimers from two subunits, p50 and p65 but 
only p65 harbors the transactivation domain required for NF-κB activation to occur 
(Karin and Ben-Neriah, 2000). Our preliminary result shows that one of the possible 
targets of suppression could be at the level of p65 as KHW inhibited about 75 % 
activation of overexpression of p65 compared to less than 20 % by bsaQ mutant. 
However, care must be taken when interpreting this result. This is because as the most 
downstream component, p65 can immediately activate a new set of signaling pathway 
such as endogeneous cytokine signaling. Hence, there is a possibility that the suppression 
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exhibited by wild-type bacteria is not targeted at p65 but components involved in the 
secondary signaling although we can eliminate the involvement of IL-1 and TNF-α since 
these cytokines are not produced in HEK293T cells. If indeed B. pseudomallei could 
inhibit overexpression of p65, it explains why wild-type bacteria could inhibit activation 
of the overexpression of intermediaries involved in conventional TLR-induced NF-κB 
activation such as MyD88, TRAF6 and IKK, which must be triggered before NF-κB 
activation can occur. Moreover, cells overexpressing TRIF also show equal sensitivity to 
suppression following infection by B. pseudomallei. As TRIF adaptor is associated with 
late NF-κB activation via TLR3 (Jiang et al., 2004) and TLR4 (Sato et al., 2003), one 
potential suppression target is at the NF-κB activation level. 
Several scenarios could account for the ability of B. pseudomallei to inhibit 
activation of p65. Firstly, B. pseudomallei might inhibit translocation of active p65 into 
the nucleus to activate gene transcription. Secondly, even if p65 translocates into the 
nucleus, B. pseudomallei might prevent binding of p65 to the DNA binding site. This can 
be achieved through the direct physical interaction with p65/NF-κB subunit, an example 
provided by Vibrio parahaemolyticus via its TTSS effector, VP1686 (Bhattacharjee et al., 
2006). Third, the ability of bacteria to prevent modification such as phosphorylation and 
acetylation on the p65 subunit can also impact the p65 transactivation potential and 
binding to DNA (Perkins et al., 2006). Lastly, B. pseudomallei might possess a protease 
that can cleave the p65 subunit interfering with activity of p65. Lad et al. has described 
this mechanism of subversion by Chlamydia trachomatis, that uses its tail-specific 
protease (CT441) to selectively cleave p65 into p40 and p22 fragments, thereby blocking 
NF-κB activation (Lad et al., 2007).   
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Although our preliminary results indicate TTSS-dependent suppression of 
p65/NF-κB could be a target of suppression, we believe this is not the only subversion 
mechanism by B. pseudomallei. Judging from our results, we hypothesized that aside 
from TTSS dependent factors, there are other modes of suppression that are independent 
of TTSS but may or may not require bacterial entry. Preventing bacterial internalization 
did not only relieve suppression in the cells infected with wild-type but also bsaQ mutant. 
Although greater TLR activation was still observed in KHW-infected cells with the 
addition of cytochalasin D, the level was still less compared to bsaQ-infected cells. bsaQ 
mutant could enter and replicate in HEK293T cells similar to wild-type (chapter 3) and 
yet it was less able to suppress TLRs. The participation of bsaQ TTSS in bacterial 
internalization is thus excluded. Importantly, eliminating B. pseudomallei bsa TTSS and 
bacterial entry completely relieved suppression in TLR2 (at low MOI but not at high 
MOI) but not in TLR4 or TLR5. Consistently, bsaQ mutant suppressed 50 % of TLR4 
and TLR5 activation compared to 25 % of TLR2 activation. This suggests participation 
of additional factors that could suppress TLR4 and TLR5 signaling without the need for 
internalization and bsa TTSS help.  
We speculate that TTSS-independent factors may act in several ways. Firstly, 
these factors could be modulating at the level downstream of IKK. bsaQ mutant partially 
subverts TNF-α and IL-1. Although the only intermediates shared between both pathways 
are downstream of IKK, similar level of suppression was observed for both. Consistently, 
bsaQ mutant also suppressed albeit only less than 20 % of overexpression of TLR 
intermediates (IKK and TRIF), thus the effect of TTSS-independent factors targeted 
along MyD88 pathway could be minimal. TTSS-independent factors (not depending on 
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bacterial entry) could be manipulating components outside the MyD88 pathway probably 
at the receptor level specifically for TLR4 and TLR5 but not TLR2. This is because the 
suppression effect is not seen with TLR2 although it shares the same MyD88 pathway as 
TLR4 and TLR5. Importantly in our system, only TLR2-transfected cells were used to 
examine interaction with bacteria. TLR2 signals also require co-receptors such as TLR1 
and TLR6 that recognize triacylated (Takeuchi et al., 2002) and diacylated lipopeptides 
(Takeuchi et al., 2001), respectively and a recent report has demonstrated that signaling 
with different coreceptors through different points of contact of the BB loop in the TIR 
domain can differentially elicit NF-κB and MAPK activation (Toshchakov et al., 2007). 
Future experiments would be to determine if cells-transfected with TLR2 and co-
receptors, TLR1 and TLR6 would be suppressed in a similar manner as that of TLR4 and 
TLR5-transfected cells upon infection with B. pseudomallei. It is important to point out 
that all studies involving overexpression of TLR intermediates in cells infected with B. 
pseudomallei are performed in cells devoid of TLR. Thus, if B. pseudomallei TTSS 
independent factor-mediated suppression requires a prior signal from TLR activation, 
then this would not be observed with the overexpression studies. Negative regulators 
such as A20 and SOCS1 are such examples that are only induced once TLR is activated 
through a negative feedback mechanism (Han and Ulevitch, 2005) and are known to be 
subverted by some microbes to block a TLR pathway. For example, M. tuberculosis is 
reported to use lipoarabinomannan to induce IRAK-M that inhibits interaction of IRAK-
TRAF6 and NF-κB activation necessary for IL-12 production via IL-4 (Pathak et al., 
2005). Recently, it was shown that measles virus P protein up-regulates ubiquitin-
modifying enzyme A20, blocking recruitment of TRAF6 formation complex with TAK1 
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and TAB2 crucial for NF-κB activation to occur (Yokota et al., 2007). Besides the 
MyD88 signaling pathway, TLR engagement also results in activation of other 
unconventional signaling components such as protein kinase C and small GTPases. 
Flagellin and LPS are shown to activate Rap1 and Ras, respectively, for activation of 
downstream ERK1/2 (Kogut et al., 2007). Additionally, in response to LPS, different 
isoforms of PKC are activated and found to associate with PI3-kinase, that influence 
activation of MAPK and NF-κB (Monick et al., 2000; Asehnoune et al., 2005; Kubo-
Murai et al., 2006; Yang et al., 2007). More importantly, PKC is not activated 
downstream of MyD88 but rather through TIRAP/Mal which is also adaptor for TLR2 
and TLR4 (Kubo-Murai et al., 2006). It is possible that B. pseudomallei TTSS-
independent factors may act through unconventional pathways via TIRAP/Mal to 
influence NF-κB activation. The capability of bacteria to inhibit more than one target to 
ensure a complete block in NF-κB activation is not an unusual phenomenon. While 
bacterium like Yersinia uses only a single molecule YopJ to affect not only MAPK but 
also acts as a deubiquitinase on TRAF2, TRAF6 and IкBα to achieve NF-κB inhibition 
(Orth et al., 1999 and 2000; Zhou et al., 2005; Sweet et al., 2007). Others like Shigella 
flexneri utilizes different effectors, OspF and OspG to block NF-κB mediated gene 
transcription via different mechanisms (Kim et al., 2005a; Arbibe et al., 2007).  
Elucidating the mechanisms of TLR subversion by B. pseudomallei will be an 
important area of research in the future. One key emphasis is to identify bacterial 
effectors responsible for the suppressive effect. Using Western blot analysis to detect 
protein intermediates that are activated following infection with wild-type, bsaQ or other 
TTSS mutants will help delineate possible pathways of subversion. So far, the use of the 
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HEK293T cells to elucidate possible mechanisms has been hampered by the existence of 
TLR dependent and independent pathways of activation triggered by B. pseudomallei. In 
our lab, we have confirmed that B. pseudomallei can exert its suppressive effect that is 
dependent on bsaQ TTSS and bacterial internalization using a macrophage cell line (Tan 
Kai Soo, unpublished data). This system will prove helpful not only as a model to 
identify bacterial effectors, but also possible pathways. The impact of TLR suppression in 
B. pseudomallei infection is still not defined in our preliminary investigation and will be 










































































5.1 Role of bsa TTSS in signaling pathways in innate immunity. 
  
Bsa TTSS has been implicated in modulation of cellular responses such as cell invasion, 
cell to cell spreading and cell death (Steven et al., 2002 and 2003; Sun et al., 2005; 
Suparak et al., 2005). We further demonstrated the involvement of bsa TTSS in signaling 
pathways governing innate immunity. In a TLR-independent manner, bsa TTSS is 
required to activate NF-κB and MAPK such as JNK and the latter seems to play a more 
pivotal role to induce IL-8. However, in a TLR-dependent manner, bsa TTSS seems to 
act in the opposite way to suppress NF-κB activation. The participating effectors in these 
two pathways remain elusive but they need not necessarily be TTSS effectors. There 
could be other non-TTSS effectors that require TTSS for delivery. For instance, 
pathogenic E. coli uses non LEE-encoded effectors that are delivered via TTSS for 
suppression (Hauf and Chakraborty, 2003; Ruchaud-Sparagano et al., 2007).  
One way to identify participating effectors is through the creation of targeted 
knockouts for known TTSS or non-TTSS effector genes. This can be achieved by 
performing homology search for pathogen effectors known to suppress TLR or activate 
IL-8 production. One TTSS candidate gene for suppression is bopB. BopB shares 
homology with Salmonella SopB (also known as SigD) that encodes a phosphatidyl 
inositol (PI) phosphatase that dephosphorylates 4’- and 5’-PIs, hence is effective in 
depleting cellular levels of phosphatidyl 4,5 bisphosphate (PIP2) (Kagan and Medzhitov, 
2006). The N-terminal of TIRAP contains PIP2 that is required for recruitment to the 
plasma membrane and expression of SopB in the cells disrupts the plasma membrane 
localization of TIRAP. This in turn affects recruitment of MyD88 to the receptor, 
resulting in decrease in NF-κB activation in response to LPS stimulation. However, the 
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role of TIRAP is not restricted to the recruitment of MyD88 as recent evidence shows 
that TIRAP but not MyD88 initiates PKC signaling leading to NF-κB activation (Kubo-
Murai et al., 2006). If BopB is the effector in B. pseudomallei-induced TLR suppression, 
it should only affect TLR2 and TLR4 as only these TLRs are known to recruit TIRAP.  
Another potential candidate is the suppressor of cytokine signaling 3 (SOCS-3). 
B. pseudomallei is known to upregulate expression of SOCS-3, which functions to 
decrease Y701-STAT-1 phosphorylation induced by IFN-γ. The reduction of IFN-γ 
signaling is associated with the failure of the B. pseudomallei-infected cells to activate 
iNOS expression (Ekchariyawat et al., 2005). Unlike SOCS-1, SOCS-3 is not known to 
be a negative regulator in TLR signaling, but studies have shown that SOCS3 can inhibit 
IL-1 signaling by preventing association between TRAF6 and TAK1 (Frobose et al., 
2006). Given that TLRs share similar signaling as IL-1R, it is highly possible that SOCS-
3 could also inhibit TLR signaling.  The simplest way to test this hypothesis is to 
determine whether the TTSS mutant exhibits reduced SOCS-3 expression compared to 
wild-type bacteria. In addition, knockdown in SOCS-3 expression by siRNA in cells 
infected with the wild-type B. pseudomallei should relieve the TLR suppression.  
To identify novel effectors, one can screen a random transposon insertion mutant 
library for mutants showing either an increase in NF-κB activation or a decrease in IL-8 
production. Previously using the same approach, we identified a few mutants using the C. 
elegans host model (Gan et al., 2002). As wild-type B. pseudomallei also suppresses 
TLR-induced NF-κB compared to bsaQ mutant in macrophage cell line, this system 
could be used to screen for potential mutants. Including an additional step such as 
centrifugation to bring down the bacteria is necessary to exclude mutants that are 
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defective in motility. To avoid false positives, the mutants should also be tested for any 
defects in invasion since bacterial entry is required for both NF-κB suppression and IL-8 
production. Identification of bacterial effectors would help to pinpoint specific 
mechanism of suppression and how they modulate host signaling proteins. Moreover, if 
the effectors are proteins, they could be expressed and purified as protein or in the form 
of an expression plasmid. Working with expression plasmids or protein molecules 
eliminate the hassle of dealing with the risk group 3 agent in a special containment 
facility and help to facilitate some experimental procedures which are not possible in the 
containment facility. 
 
5.2 The physiological relevance of the TLR-independent, TTSS-dependent IL-8 
production in B. pseudomallei pathogenicity 
Melioidosis is characterized by massive influx of neutrophils and although high IL-8 
concentration was found in plasma during septicemic and localized infection (Friedland 
et al., 1992), no report has directly shown that IL-8 could be the major chemokine in 
neutrophils recruitment. We show that B. pseudomallei is capable of inducing IL-8 in a 
TTSS-dependent, but in a TLR-independent pathway. This mode of induction might be 
particularly relevant in mucosal infection whereby epithelial cells express little TLRs. 
Moreover, mounting evidence points to epithelial cells being the major cell type in 
mucosa to initiate secretion of IL-8 (Sansonetti et al., 1999).  
One could model this interaction using an in vitro system of polarized epithelial 
cells. Previously we found that B. pseudomallei could induce IL-8 from polarized Caco-2 
cells, which is derived from the colon. Ideally, studies modeling how bacteria interact 
with the primary defensive barrier during an in vivo mucosal infection should employ 
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epithelial cells derived from lung and bronchia such as Calu-3 and 16HBE14o-, 
respectively. Both of these cell lines are reported to form polarized monolayers with 
intact tight junctions and express differentiated features of the native epithelium (Cozen 
et al., 1994; Shen et al., 1994; Wan et al., 2000). Epithelial cells grown either in a 
vertical (Fig. 5.2.1A) or an inverted manner (Fig. 5.2.1B) (McComick, 2003) could be 
used to monitor whether apical or basal stimulation by bacteria can lead to polarized IL-8 
secretion and if there is a differential IL-8 production between wild-type and TTSS 
mutants or other non-pathogenic bacterial strains. In the transepithelial model studies 
with Salmonella, only apical but not basal application of the bacteria resulted in IL-8 
secretion into the basolateral site (McComick et al., 1993) but whether the same scenario 
applies to B. pseudomallei still needs further investigation as we did not observe this with 
Caco-2 cells.  Apart from that, the inverted model of epithelial cells can be used to 
examine whether B. pseudomallei-triggered IL-8 is sufficient to drive neutrophils 
transmigration across the epithelial layer leading to greater epithelial permeability. In the 
PMN transmigration assay, neutrophils placed on the basolateral chamber (facing 
upwards) should migrate into the apical site when the cells are infected wild-type but to a 
lesser extent with the mutants. Following the migration, the corresponding TEER could 
also be determined. Moreover, cytochalasin D and MAPK inhibitors could also be used 
in this system to see if the mechanisms of IL-8 production in HEK293T cells reflect that 
of polarized epithelial cells.  
 IL-8 induction is thought to be essential for early, non-specific eradication of 
bacteria through recruitment of neutrophils although it could also result in tissue 
destruction. In a melioidosis case study, fifty percent of patients who died have detectable 
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IL-8 but not other cytokines, suggesting its correlation with disease severity (Friedland et 
al., 1992). The C57BL/6 mouse model which was previously established to model 
chronic B. pseudomallei infection (Leakey et al., 1998; Liu et al., 2002) will be useful in 
defining the role of IL-8 or the mouse equivalent chemokine (KC) during B. 
pseudomallei infection to see if it closely mirrors the in vitro observation. Mice do not 
have the IL-8 gene. However, murine homologues of human IL-8R such as IL-8RA 
(CXCR1) and IL-8RB (CXCR2) have been identified and are found to respond to various 
CXC chemokines specifically, CXCR1 that is activated by human IL-8 (CXCL8) 
(Guenet, 2005; Fan et al., 2007). B. pseudomallei TTSS-dependent induction of IL-8 
presumably is only important in epithelial cells whereby TLR expression is reduced. 
Hence, wild-type and TTSS mutant bacteria can be administered via the intranasal route 
into mice for subsequent studies. Mice infected via the intraveneous route however could 
be used as a negative control to verify the impact of TLR-independent IL-8 production in 
mucosal infection. Firstly, the kinetics of KC chemokine production in the mucosa could 
be determined. Theoretically, wild-type bacteria should be able to induce high level of 
KC chemokine compared to the mutants. As reports have shown that apart from epithelial 
cells, infiltrating macrophages, neutrophils and endothelial cells can also produce IL-8 
(Baggiolini et al., 1994; Daig et al., 1996; Grimm et al., 1996; Curf et al., 1997), so 
immunohistochemical staining for the KC chemokine in tissue sections from the mucosal 
surface could help to delineate whether epithelial cells are the major source of IL-8 
production.  IL-8 induction correlates with severity of epithelial destruction in the 
Shigella infection (Sansonetti et al., 1999). Hence, a histopathological inspection of 
tissues such as altered villi and epithelial lining, abscesses formation and for sign of 
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neutrophil infiltration can be performed. As it has been shown experimentally in 
Salmonella typhimurium infection (McCormick et al., 1993), factors other than IL-8 are 
responsible for neutrophil transmigration. Thus, it is essential to include KC chemokine 
neutralization studies with the antibodies prior to infection to examine exactly the role of 
KC chemokine in recruitment of neutrophils. KC chemokine induction is reported to 
correspond to greater bacterial invasion and contributes more destruction in Shigella and 
Salmonella infection (McCormick et al., 1993; Sansonetti et al., 1999). To see if this is 
true in B. pseudomallei infection, the number of bacteria in the mucosal epithelial as well 
as in blood stream and organs would be enumerated to see if greater KC chemokine 
induction actually facilitates bacterial spreading. Production of other inflammatory 
cytokines such as IL-6, IL-1 and TNF-α could be determined to see if they correspond to 
greater bacterial loads and mortality in mice. 
 
Figure 5.2.1 A representation of a transepithelial model. (A) A vertical epithelial 
model is where the epithelial cells grow normally on a permeable support allowing the 
study of direct interaction between bacteria and apical epithelial surface. (B) The inverted 
epithelial model is where epithelial cells grow in an inverted manner before the filter is 
placed right side up so that the top of the permeable support represents the underlying 
basolateral surface. Bacteria maybe infected apically or basolaterally but neutrophils are 
usually placed on the basolateral surface. This orientation is usually used to study the 
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effect of bacteria on neutrophil transmigration. This figure is adapted from McCormick, 
2003. (Reproduced with permission from Elsevier Limited) 
 
5.3 Mechanisms of B. pseudomallei-induced suppression of TLR signaling 
 
We have found that B. pseudomallei is able to suppress TLR activation which is 
dependent on TTSS.  Wild-type bacteria are able to inhibit p65 compared to bsaQ 
mutant, suggesting that the suppression target could be at the level of the p65 subunit. 
However, wild-type B. pseudomallei also activates NF-κB independent of TLR in the 
HEK293T cell line; hence, these two different pathways could neutralize each other. It is 
also not possible to differentiate the key signaling intermediates such as IKK, IκB and 
p65/NF-κB shared by these two pathways. Using an alternative macrophage cell line 
(RAW264.7), we saw a similar phenomenon as in the HEK293T cell line with lower 
activation of NF-κB in cells infected with wild-type compared to bsaQ mutant. 
Consistent with HEK293T, wild-type bacteria also suppress activation of TLR agonists in 
a dose-dependent manner (Tan Kai Soo, unpublished data). As the macrophage cell line 
contains intrinsic TLR expression, this eliminates the hassle of transfection and 
concurrently, this system will be helpful for screening bacterial effectors as well as 
identification of possible pathways involved.  Several likely scenarios could account for 
subversion at the level of p65 by B. pseudomallei.  The most direct reason could be that 
p65 is prevented from translocation into the nucleus. However, failure of p65 to initiate 
transcription could also be due to other reasons. p65 is less phosphorylated hence reduced 
in its transcriptional activation potential (Perkins, 2006), physical hindrance by bacterial 
effectors preventing its binding to target gene or modification of p65 such as cleavage by 
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bacterial protease. One could employ Western blotting to distinguish between these 
possibilities. Antibodies against phosphorylated p65 either against the cytoplasmic or 
nucleus lysate obtained from wild-type would exhibit reduced p65 compared to bsaQ 
mutant if it is due to lack of phosphorylation or nucleus tanslocation, respectively. If p65 
is intact and not cleaved, antibodies against different p65 segments such as against p40 
and p22 should only exhibit a single band in Western blotting. Technique such as 
electrophoretic mobility shift assay (EMSA) will help to determine whether reduced NF-
κB in wild-type is due to failure of p65 to bind to target DNA. Another likelihood that is 
of equal importance is epigenetic modifications such as phosphorylation or acetylation of 
histones. OspF of Shigella is reported to inhibit histone H3 phosphorylation via MAPK 
pathway which masks the NF-κB binding site for transcription of a subset of genes 
(Arbibe et al., 2007).  
We believe suppression at p65 is not the sole contributor to lower activation of 
NF-κB observed in wild-type compared to TTSS mutant. Preventing bacterial entry also 
elevates NF-κB activation level not only in wild-type but also bsaQ mutant. Moreover, 
increase in NF-κB activation in cytochalasin D-treated cells infected with wild-type is not 
comparable to bsaQ mutant infected but non cytochalasin D-treated cells, suggesting that 
bacterial entry and TTSS are two independent factors both contributing to the suppressive 
effect. To distinguish between these two contributory factors, one can use Western 
blotting with antibodies to different signaling intermediates TRAF6, IKK or MAPK using 
lysate from cells with a combination of different treatments (cytochalasin D versus non-
treated) or infection (wild-type versus bsaQ mutant), unless all these factors converge on 
the same molecules. 
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Modulation of signaling pathways by microbes could also be through direct 
binding of bacterial effectors with signaling components. Hence knowing the 
participating bacterial effectors or affected signaling components would be of great 
advantage. These molecules could be used as probes to fish out the interacting proteins, 
providing us with the insights into the mechanisms of suppression.  
 
5.4 Effect of B. pseudomallei-induced suppression of TLRs on immunity 
Mounting evidence shows that activation of different TLRs initiates distinct immune 
responses against pathogens. In the antifungal activity of PMNs elicited by TLR 
engagement, production of reactive oxygen species is mostly mediated by zymosan while 
azurophilic granules with myeloperoxidase activity are induced by LPS (Bellocchio et 
al., 2004). In another example, intracellular growth of L. pneumophila and C. burnetii is 
enhanced in TLR2-/- which is associated with reduced cytokine production compared to 
TLR4-/- and wild-type macrophages, showing the predominant role of TLR2 but not 
TLR4 in murine innate immunity against these bacterial pathogens (Zamboni et al., 2004; 
Akamine et al., 2005). Dendritic cells upon contact with C. pneumoniae potently 
upregulate costimulatory and MHC class two molecules as well as cytokines such as 
TNF-α that are dependent of TLR2 but not TLR4 (Prebeck et al., 2001).The differential 
roles played by TLR in immunity against pathogens have also been demonstrated from 
studies involving TLR knockout (KO) mice. For instance, depending on fungal species, 
morphology as well as the route of the infection, different members of the IL-1R/TLR 
superfamily might be activated alone or in a coordinated manner to generate protective 
innate and adaptive immunity to C. albicans and A. fumigatus infection (Bellochio et al., 
2004).  
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 Previously, we have found that B. pseudomallei suppressed TLR2, TLR4 and 
TLR5 which was dependent on the bsa TTSS. MyD88-dependent signaling has been 
associated with development of both innate and adaptive immunity, and MyD88 deficient 
mice are shown to be susceptible to bacterial infection (Jankovic et al., 2002; Scanga et 
al., 2002; Bellocchio et al., 2004; Pasare and Medzhitov, 2004). We hypothesize that B. 
pseudomallei-induced subversion of TLRs alters the immune response facilitating 
bacterial survival in the host cells. In fact, many pathogens modulate TLR signaling 
pathways to suppress immune response (Tato and Hunter, 2002; Bellochio et al., 2004, 
Netea et al., 2004). Murine models would be useful model to decipher the outcome of B. 
pseudomallei-induced suppression of TLRs. Two approaches are available. Firstly, 
comparison could be made between different TLR KO mice with wild-type mice upon 
infection with wild-type bacteria. Alternatively, wild-type mice such as C57BL/6 mice 
infected with the wild-type or mutant bacteria defective in suppression could be 
compared. As immune responses elicited by activation of TLRs vary with the routes of 
infection (Bellocchio et al., 2004; Mazzoni and Segal, 2004), bacteria could be 
administered either via intranasal or intraperitoneal route to see if there are differences 
between the two. Using these approaches, several questions will be addressed: (1) 
whether TLR subversion contributes to susceptibility or resistance to B. pseudomallei 
infection, (2) whether each of these TLRs contributes to distinct, coordinated or 
redundant roles in immunity.  
Based on our hypothesis, TLR KO mice should be more susceptible compared to 
wild-type mice in response to bacterial infection. Likewise, wild-type mice should be 
able to resist infection by mutant bacteria compared to wild-type bacteria. However, not 
 166
all TLRs mediate the same immune response, and the same protection. While some of the 
TLRs have been shown to play redundant roles (Skerrett et al., 2007), studies have also 
shown cooperation between different TLRs for optimal shaping of the immune response 
(Roeder et al., 2004; Bafica et al., 2005; Lee et al., 2007). Therefore, inclusion of 
MyD88 KO mice (Adachi et al., 1998) would be useful to delineate cooperative effects of 
TLRs in mediating protection in B. pseudomallei infection.  
To correlate the susceptibility of KO mice with a lack of innate immunity, the 
extent of neutrophil and macrophage infiltration of into the lung should be assessed to see 
if it correlates with an increase in bacterial load in the lung. Previously, neutrophils and 
macrophages have been implicated in protection against B. pseudomallei infection in the 
mouse model (Breitbach et al., 2006; Easton et al., 2007). Correspondingly, 
proinflammatory cytokines and chemokines obtained from nasal and bronchioalveolar 
washes and sera very early in infection might be more pronounced in wild-type compared 
to KO mice. However, the increasing bacterial loads in the KO mice with time could 
result in hyperinflammation in these mice at later time-points due to subsequent 
infiltration of cells. It is also likely that TLRs also modulate bactericidal activity in the 
innate immune cells. TLR4 signaling is known to augment neutrophil migration by 
modulation of cell surface expression of chemokine receptors (Fan and Malik, 2003). The 
phagocytosis and killing ability of PMNs from MyD88 KO and IL-1R KO mice against 
Candida yeasts were completely abolished. In the case of Aspergillus conidia, 
phagocytosis and killing ability of PMNs were impaired in MyD88 KO mice and 
particularly in TLR4 KO mice (Bellocchio et al., 2004). To determine if in vivo 
susceptibility in TLR KO mice is due to defective effector functions in immune cells, the 
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bactericidal activity such as the ability to phagocytose and killing mechanisms through 
oxidative (respiratory burst) and non-oxidative (myeloperoxidase, defensins) mechanisms 
could be determined from infected neutrophils and macrophages isolated from the wild-
type and KO mice.   
TLRs are also known to modulate adaptive immunity. To determine if 
susceptibility of KO mice may also be due to failure to generate a T helper (Th) cell type 
1 response, the IFN-γ and IL-4 producing CD4+ T lymphocytes could be determined in 
both wild-type and KO mice. Dendritic cells (DC) through activation of TLRs play an 
instrumental role in shaping the adaptive Th response. Interaction of TLRs with microbial 
products causes DC to migrate from the peripheral tissues to lymphoid organs and up-
regulate MHC and costimulatory molecules to prime naïve T cells. Moreover, DC plays a 
decisive role in the character of the ensuing immune response by secreting cytokines that 
drive the development of the T cells into Th1, Th2 or T regulatory (Treg) effector cells 
(Mazzoni and Segal, 2004). Studies have shown that TLR-induced DC maturation and 
migration to the lymph nodes, without the presence of TLR-induced inflammatory 
cytokines are not sufficient for T cell activation in vivo (Pasare and Medzhitov, 2004). To 
determine if these possibilities play a part in B. pseudomallei infection, DCs derived from 
each type of these mice in response to B. pseudomallei can be assessed for 1) ability to 
phagocytosis, 2) T cell activation, and 3) cytokine production. Specifically, IL-12 p75 
and IL-27 are known to drive polarization of T cells toward the Th1 phenotype, but 
others also indicate that the type 1 IFNs are capable of inducing Th1 cells (Cella et al., 
2000; Nguyen et al., 2002; Trinchieri et al., 2003). Conversely, exposure of T cells to IL-
4, IL-5 and IL-10 and IL-6 (Diehl et al., 2000) in the mouse system contribute to the 
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induction of Th2 responses, and IL-10 also promotes T regulatory cell induction 
(Roncarolo et al., 2001).  
Our proposed studies on the susceptibility of TLR KO mice to B. pseudomallei so 
far is based on the hypothesis that TLR is required to instruct protective, pro-
inflammatory response against infection. However, Higgins et al. has illustrated 
otherwise. TLR4 KO mice are shown to be susceptible to B. pertussis infection not 
because of the lack of protective immunity. In fact, TLR4 KO mice exhibit enhancement 
in antibody- and antigen- specific IFN-γ production. In that study, susceptibility is caused 
by overt production of inflammatory cytokine production, cellular infiltration and severe 
pathological changes in lungs of the KO mice which is due to lower production of IL-10 
contributing to lack of Treg cells to balance the inflammatory response (Higgins et al., 
2003).  
Recently, infection by B. pseudomallei indicated TLR2 but not TLR4 KO mice 
could survive better than normal mice as reflected by lower bacterial loads and less 
distant-organ injury (Wiersinga et al., 2007).  These workers claimed that B. 
pseudomallei LPS which signals through TLR2/CD14 leads to sepsis in B. pseudomallei 
infection. This study seems to contradict our hypothesis that B. pseudomallei prevents 
TLR activation presumably to reduce immune response. This could be a temporal issue 
where continue TLR signaling via TLR2 leads to overt inflammation and tissue 
destruction. As the suppression is not complete, the activation is likely sufficient to drive 
tissue injury. TLR suppression may be important in initial encounter of the bacteria with 
host cells to dampen the immune response. Alternatively, suppression of TLRs may be 
beneficial to the host. If such is the case, mutant bacteria which could no longer suppress 
 169
activation of TLR2 would result in greater host death. Wiersinga et al. reported only the 
lack of TLR2 is protective, while in our system suppression of more than one TLR 
occurred, we hypothesize it is more likely that other TLRs could be protective even if 
TLR2 is not. 
 
5.5 Concluding remarks 
 
Melioidosis remains a potentially life threatening disease in endemic regions.  Treatment 
of this disease is particularly difficult given that the bacteria are intrinsically resistant to 
many antibiotics. Furthermore, despite intensive antibiotic treatment, recurrence of 
infection is very common. Although vaccination represents the best option to protect the 
people at risk, the progress has been slow and hampered by relatively lack of putative 
virulence factors that are uncovered and their uncharacterized roles in B. pseudomallei 
pathogenesis. One of the crucial determinants is B. pseudomallei bsa TTSS that has been 
implicated in modulation in many aspects of cellular responses in the host. We show that 
B. pseudomallei bsa TTSS is involved in the regulation of the innate immune response. 
Specifically, TTSS is required to elicit IL-8 from TLR deficient cells such as epithelial 
cells. Presumably, this will initiate the onset of mucosal inflammatory response. Based on 
these findings, once can postulate that inhibition of MAPK-induced IL-8 production in 
combination with antibiotic treatment might prove helpful to overcome acute melioidosis. 
In addition, B. pseudomallei bsa TTSS suppresses TLR signaling. Identification of 
bacterial effectors can aid in identification of the suppression mechanisms and its impact 
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Interaction of Burkholderia pseudomallei with mucosal epithelial cells 
Chung-Shii Hii and Yunn-Hwen Gan 
Department of Biochemistry, National University of Singapore, 8 Medical Drive,  
Singapore 117597 
 
In this study, we examined the interaction of B. pseudomallei, strain KHW, with 
polarised mucosal epithelial cell-line, Caco-2. KHW is capable of invading and 
replicating in Caco-2 cells. Our results also show that KHW could mediate reduction in 
TEER in a time dependent manner and this effect is not due to cell lysis. This 
demonstrates that although KHW could invade, there is a likelihood that KHW gain 
access to the underlying tissue via a paracellular pathway, possibly through the 
destruction of epithelial tight junctions proteins. On the other hand, functionally intact 
Caco-2 cells could respond to apical KHW infection by secreting IL-8 in a basolaterally-
polarized manner.This polarized IL-8 production might be important for recruitment of 
PMN to the site of infection. Moreover, KHW mediate activation of NF-kB, which is the 
key regulator for activating the inflammatory response genes. Taken together, these 
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results suggest the presence of mechanisms in the bacteria that provoke an innate immune 
response in the mucosa when invaded. 
 
2. Keystone Symposium, 6th-11th, Jan 2006, USA 
 
Interaction and suppression of Toll-like receptors by Burkholderia pseudomallei 
Chung-Shii Hii, Jinhua Lu and Yunn-Hwen Gan 
 Department of Biochemistry, National University of Singapore, 8 Medical Drive, 
Singapore 117597 
 
The Gram-negative bacillus B. pseudomallei is the causative agent of melioidosis, an 
infectious disease which is endemic in Southeast Asia and northern Australia. B. 
pseudomallei is well-equipped with many virulent factors which contribute to its survival 
and pathogenicity, one of which is the bsa type III secretion systems (TTSS), which 
resembles the inv/spa/prg TTSS of Salmonella typhimurium. In the interaction with 
macrophages, we found that B. pseudomallei does not induce a strong cytokine response 
compared to other Gram-negative bacteria. We further examine the interaction with Toll-
like receptors and found that live B. pseudomallei is unable to activate TLR2 while heat-
inactivated bacteria could activate both TLR2 and TLR4.  This is also in contrast to live 
B. thailandensis, an avirulent species, which activates both TLR2 and TLR4. We 
postulate that live B. pseudomallei possesses active means to suppress TLR2. We found 
that bsa TTSS of B. pseudomallei is involved in the suppression as the bsaQ mutant, 
which has a functional defect in TTSS, activates higher NF-κB level in the 293T cells 
transfected with TLRs compared to wild type bacteria. Furthermore, we are examining 
whether B. pseudomallei is able to suppress TLR agonists-induced NF-κB activation. 
Activation of either TLR2 or TLR4 might lead to different patterns of host defense 
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against the pathogen. Our studies showing that B. pseudomallei, which unable to activate 
TLR2, induces poor inflammatory response compared to heat-inactivated B. 
pseudomallei, B. thailandensis and E. coli, which activate TLR2, are suggestive of this. 
Hence, it is of our interest to unravel the mechanisms by which B. pseudomallei interferes 
with TLR signaling pathway and to see how B. pseudomallei-induced suppression could 




1. Media and supplements 
 
 Luria-Bertani (LB) agar or LB broth 
 
Bacto-tryptone (Becton Dickinson) 1 % (w/v) 
 
Yeast extract (Becton Dickinson) 1 % (w/v) 
 
NaCl (Merck)    0.5 % (w/v) 
 
pH 7 with 1 M NaOH    
 
1.5 % (w/v) technical agar- for LB agar (Becton Dickinson) 
 
Autoclaved at 121 °C, 15 PSI for 15 minutes. 
 




Fetal calf serum (FCS)  10 % 
 
L-glutamine    2 mM 
 
Penicillin    100 Unit/ ml 
 









Fetal calf serum (FCS)  20 % 
 
L-glutamine    2 mM 
 
Penicillin    100 Unit/ ml 
 
Streptomycin    100 μg /ml 
 
Pyruvate    1 mM 
 
 
2. Western blot buffers 
 
2.1 1.5 M-Tris-HCl-buffer, pH 8.8 
 
   Trizma base (Sigma)   18.2 g 
 
   Deionised water   80.0 ml 
 
The pH was adjusted to 8.8 with concentrated HCl and made up to  
 
100 ml with deionised water and stored at 4 °C. 
 
       2.2 0.5 M-Tris-HCL buffer, pH 6.8 
 
   Trizma base (Sigma)   6.0 g 
    
   Deionised water    80 ml 
 
   The pH was adjusted to 6.8 with concentrated HCl and made up to   
 
                                    100 ml with deionised water and stored at 4 °C. 
 
       2.3 10 % (w/v) SDS solution 
 
   Sodium dodecyl sulphate   10.0 g 
 
   Deionised water   100 ml 
 




       2.4 10 % (w/v) ammonium persulphate solution 
 
   Ammonium persulphate  0.1 g 
 
   Deionised water    1.0 ml 
 
   The solution was always freshly prepared prior to use. 
 
 
      2.5 Running buffer 
 
   Trizma base    6 g 
 
   Glycine    28.8 g 
 
   10 % SDS (w/v)   10 ml 
 
   Deionised water   1 liter 
 
   Stored at 4 °C. 
 
      2.6 6X sample loading buffer 
 
   0.5 M-Tris-HCl-buffer, pH 6.8 2.50 ml 
 
   Glycerol    2.00 ml 
 
   SDS 10 % solution (w/v)  4.00 ml 
 
   DTT     0.31 g 
 
   Bromophenol blue   0.10 mg 
 
   Made up to 10 ml with water. The buffer was stored as 1 ml  
 













2.7 Gel preparation (for 1 Mini-Protean gel) 
 
Composition of the separating and stacking gels in SDS-PAGE. 
 




1.5 M-Tris-HCL buffer pH 8.8 
 





































   
 
* refers to the total acrylamide content 
 
** TEMED was added immediately before the casting of the slab gel 
 
